# EDGAR Filing Document

**Accession Number:** 0001113169
**File Stem:** 0001628280-25-047751
**Filing Date:** 2025-10
**Character Count:** 165574
**Document Hash:** 1eb31d02c3bfdeaaf95ed0d0ba0cf285
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-047751.hdr.sgml**: 20251031

**ACCESSION NUMBER**: 0001628280-25-047751

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 80

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251031

**DATE AS OF CHANGE**: 20251031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PRICE T ROWE GROUP INC
- **CENTRAL INDEX KEY:** 0001113169
- **STANDARD INDUSTRIAL CLASSIFICATION:** INVESTMENT ADVICE [6282]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 522264646
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-32191
- **FILM NUMBER:** 251439711

**BUSINESS ADDRESS:**
- **STREET 1:** HARBOR POINT
- **STREET 2:** 1307 POINT STREET
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21231
- **BUSINESS PHONE:** 4103452000

**MAIL ADDRESS:**
- **STREET 1:** HARBOR POINT
- **STREET 2:** 1307 POINT STREET
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21231

?xml version='1.0' encoding='ASCII'? trow-20250930

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

______________________________________

**FORM 10-Q** 

______________________________________

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended September 30, 2025** 

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from to** 

**Commission File Number: 000-32191** 

______________________________________

**T. ROWE PRICE GROUP, INC.**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Maryland** | **52-2264646** |
| **(State of incorporation)** | **(I.R.S. Employer Identification No.)** |

---

**1307 Point Street, Baltimore, Maryland 21231** 

**(Address, including Zip Code, of principal executive offices)**

**(410) 345-2000** 

**(Registrant's telephone number, including area code)**

________________

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| **Common Stock, $0.20 par value per share** | **TROW** | **The NASDAQ Stock Market LLC** |

---

______________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;☒ Yes&nbsp;&nbsp;&nbsp;&nbsp;☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;☒ Yes&nbsp;&nbsp;&nbsp;&nbsp;☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer" "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| Non-accelerated filer | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes&nbsp;&nbsp;&nbsp;&nbsp;☒ No

The number of shares outstanding of the issuer's common stock ($0.20 par value), as of the latest practicable date, October 29, 2025, is 218,237,000.

The exhibit index is at Item 6 on page 44.

------

**PART I – FINANCIAL INFORMATION**

**Item 1. Financial Statements.**

**UNAUDITED CONSOLIDATED BALANCE SHEETS**

**(in millions, except share data)**

---

| | | |
|:---|:---|:---|
| | **9/30/2025** | **12/31/2024** |
| **ASSETS** | | |
| &nbsp;&nbsp;Cash and cash equivalents | $3634.8 | $2649.8 |
| &nbsp;&nbsp;Accounts receivable and accrued revenue | 899.4 | 877.4 |
| &nbsp;&nbsp;Investments | 3417.4 | 3000.5 |
| &nbsp;&nbsp;Assets of consolidated investment products ($1,599.8 million at September 30, 2025 and $1,555.6 million at December 31, 2024, related to variable interest entities) | 1777.7 | 2044.0 |
| &nbsp;&nbsp;Operating lease assets | 392.2 | 226.8 |
| &nbsp;&nbsp;Property, equipment and software, net | 980.9 | 977.0 |
| &nbsp;&nbsp;Intangible assets, net | 294.6 | 368.1 |
| &nbsp;&nbsp;Goodwill | 2642.8 | 2642.8 |
| &nbsp;&nbsp;Other assets | 690.6 | 685.6 |
| Total assets | $14730.4 | $13472.0 |
| **LIABILITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | $349.5 | $353.5 |
| &nbsp;&nbsp;Liabilities of consolidated investment products ($21.7 million at September 30, 2025 and $46.2 million at December 31, 2024, related to variable interest entities) | 22.7 | 62.1 |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities | 455.1 | 278.7 |
| &nbsp;&nbsp;&nbsp;Accrued compensation and related costs | 793.8 | 219.8 |
| &nbsp;&nbsp;&nbsp;Deferred compensation liabilities | 1093.2 | 1020.7 |
| &nbsp;&nbsp;&nbsp;Income taxes payable | 46.7 | 87.1 |
| Total liabilities | 2761.0 | 2021.9 |
| Commitments and contingent liabilities |  |  |
| Redeemable non-controlling interests | 984.9 | 944.0 |
| **STOCKHOLDERS' EQUITY** |  |  |
| &nbsp;&nbsp;Preferred stock, undesignated, $0.20 par value – authorized and unissued 20,000,000 shares |  |  |
| &nbsp;&nbsp;Common stock, $0.20 par value—authorized 750,000,000; issued 218,684,000 shares at September 30, 2025 and 222,966,000 at December 31, 2024 | 43.7 | 44.6 |
| &nbsp;&nbsp;&nbsp;Additional capital in excess of par value |  | 311.9 |
| &nbsp;&nbsp;&nbsp;Retained earnings | 10817.3 | 10040.6 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (46.5) | (51.7) |
| Total stockholders' equity attributable to T. Rowe Price Group, Inc. | 10814.5 | 10345.4 |
| Non-controlling interests in consolidated entities | 170.0 | 160.7 |
| Total permanent stockholders' equity | 10984.5 | 10506.1 |
| Total liabilities, redeemable non-controlling interests, and permanent stockholders' equity | $14730.4 | $13472.0 |

---

The accompanying notes are an integral part of these statements.

------

**UNAUDITED CONSOLIDATED STATEMENTS OF INCOME**

**(in millions, except per-share amounts)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Nine months ended** | **Nine months ended** |
| | **9/30/2025** | **9/30/2024** | **9/30/2025** | **9/30/2024** |
| Revenues |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Investment advisory fees | $1698.7 | $1627.3 | $4864.7 | $4732.5 |
| &nbsp;&nbsp;&nbsp;Performance-based advisory fees | 6.4 | 5.6 | 23.2 | 40.0 |
| &nbsp;&nbsp;&nbsp;Capital allocation-based income | 42.0 | 4.6 | 40.4 | 51.8 |
| &nbsp;&nbsp;&nbsp;Administrative, distribution, services, and other fees | 146.4 | 148.1 | 452.4 | 444.8 |
| &nbsp;&nbsp;&nbsp;Net revenues | 1893.5 | 1785.6 | 5380.7 | 5269.1 |
| Operating expenses |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Compensation and related costs | 714.3 | 678.3 | 2106.5 | 2048.4 |
| &nbsp;&nbsp;&nbsp;Distribution and servicing | 95.8 | 91.6 | 281.9 | 261.2 |
| &nbsp;&nbsp;&nbsp;Advertising and promotion | 21.3 | 20.8 | 77.3 | 79.4 |
| &nbsp;&nbsp;&nbsp;Product and recordkeeping related costs | 78.7 | 75.0 | 237.3 | 223.0 |
| &nbsp;&nbsp;&nbsp;Technology, occupancy, and facility costs | 183.2 | 164.0 | 530.2 | 474.8 |
| &nbsp;&nbsp;&nbsp;General, administrative, and other | 101.7 | 104.2 | 314.5 | 305.5 |
| &nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration |  | (13.4) |  | (13.4) |
| &nbsp;&nbsp;&nbsp;Acquisition-related amortization and impairment costs | 26.8 | 51.5 | 86.7 | 125.3 |
| &nbsp;&nbsp;&nbsp;Restructuring charge | 28.5 |  | 28.5 |  |
| &nbsp;&nbsp;&nbsp;Total operating expenses | 1250.3 | 1172.0 | 3662.9 | 3504.2 |
| Net operating income | 643.2 | 613.6 | 1717.8 | 1764.9 |
| Non-operating income (loss) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net gains (losses) on investments | 161.2 | 119.0 | 359.0 | 318.5 |
| &nbsp;&nbsp;&nbsp;Net gains (losses) on consolidated investment products | 72.6 | 85.9 | 183.1 | 166.7 |
| &nbsp;&nbsp;&nbsp;Other gains (losses), including foreign currency gains (losses) | 4.6 | 7.6 | 2.5 | (3.5) |
| &nbsp;&nbsp;&nbsp;Total non-operating income (loss) | 238.4 | 212.5 | 544.6 | 481.7 |
| Income before income taxes | 881.6 | 826.1 | 2262.4 | 2246.6 |
| Provision for income taxes | 195.1 | 185.7 | 514.7 | 527.5 |
| Net income | 686.5 | 640.4 | 1747.7 | 1719.1 |
| &nbsp;&nbsp;&nbsp;Less: net income (loss) attributable to redeemable <br>non-controlling interests | 40.4 | 37.4 | 105.9 | 58.9 |
| Net income attributable to T. Rowe Price Group, Inc. | $646.1 | $603.0 | $1641.8 | $1660.2 |
| Earnings per share on common stock of T. Rowe Price Group, Inc. |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $2.88 | $2.64 | $7.26 | $7.25 |
| &nbsp;&nbsp;&nbsp;Diluted | $2.87 | $2.64 | $7.25 | $7.23 |

---

The accompanying notes are an integral part of these statements.

------

**UNAUDITED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

**(in millions)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Nine months ended** | **Nine months ended** |
| | **9/30/2025** | **9/30/2024** | **9/30/2025** | **9/30/2024** |
| Net income | $686.5 | $640.4 | $1747.7 | $1719.1 |
| Other comprehensive income (loss) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Currency translation adjustments |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Consolidated investment products - variable interest entities | (5.2) | 16.9 | 22.2 | 13.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification (gains) losses recognized in non-operating income upon deconsolidation of certain investment products |  | 0.6 | (3.1) | 0.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity method investments | (0.2) | 0.1 | (3.7) | 0.6 |
| Other comprehensive income (loss) before income taxes | (5.4) | 17.6 | 15.4 | 14.3 |
| &nbsp;&nbsp;&nbsp;Net deferred tax (expense) benefit | 0.7 | (0.5) | (2.0) | (0.1) |
| Total other comprehensive income (loss) | (4.7) | 17.1 | 13.4 | 14.2 |
| Total comprehensive income | 681.8 | 657.5 | 1761.1 | 1733.3 |
| &nbsp;&nbsp;&nbsp;Less: comprehensive income attributable to redeemable non-controlling interests | 37.6 | 44.8 | 114.1 | 65.1 |
| Comprehensive income attributable to T. Rowe Price Group, Inc. | $644.2 | $612.7 | $1647.0 | $1668.2 |

---

The accompanying notes are an integral part of these statements.

------

**UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS** 

**(in millions)**

---

| | | |
|:---|:---|:---|
| | **Nine months ended** | **Nine months ended** |
| | **9/30/2025** | **9/30/2024** |
| Cash flows from operating activities |  |  |
| &nbsp;&nbsp;&nbsp;Net income | $1747.7 | $1719.1 |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation, amortization and impairment of property, equipment and software | 203.7 | 188.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization and impairment of acquisition-related assets and retention arrangements | 165.8 | 196.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fair value remeasurement of contingent consideration liability |  | (13.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 134.2 | 162.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gains recognized on investments | (347.5) | (332.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net redemptions in investment products used to economically hedge deferred compensation liabilities | 110.0 | 29.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change in securities held by consolidated investment products | (821.4) | (517.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other changes in assets and liabilities | 579.6 | 534.9 |
| &nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 1772.1 | 1967.5 |
| Cash flows from investing activities |  |  |
| &nbsp;&nbsp;&nbsp;Purchases of sponsored investment products | (134.9) | (89.4) |
| &nbsp;&nbsp;&nbsp;Dispositions of sponsored investment products | 473.0 | 303.1 |
| &nbsp;&nbsp;&nbsp;Net cash of investment products upon consolidation (deconsolidation) | (35.8) | (15.7) |
| &nbsp;&nbsp;&nbsp;Additions to property, equipment and software | (207.5) | (310.4) |
| &nbsp;&nbsp;&nbsp;Other investing activity | (113.7) | (42.6) |
| &nbsp;&nbsp;&nbsp;Net cash used in investing activities | (18.9) | (155.0) |
| Cash flows from financing activities |  |  |
| &nbsp;&nbsp;&nbsp;Repurchases of common stock | (481.8) | (269.1) |
| &nbsp;&nbsp;&nbsp;Common share issuances under stock-based compensation plans | 30.2 | 28.1 |
| &nbsp;&nbsp;&nbsp;Dividends paid to common stockholders and equity-unit holders | (858.5) | (851.0) |
| &nbsp;&nbsp;&nbsp;Net contributions (distributions) to non-controlling interests in consolidated entities | (5.6) | 2.6 |
| &nbsp;&nbsp;&nbsp;Net subscriptions from redeemable non-controlling interest holders | 530.1 | 361.2 |
| &nbsp;&nbsp;&nbsp;Net cash used in financing activities | (785.6) | (728.2) |
| Effect of exchange rate changes on cash and cash equivalents of consolidated investment products | 3.4 | 0.5 |
| Net change in cash and cash equivalents during period | 971.0 | 1084.8 |
| Cash and cash equivalents at beginning of period, including $63.1 million at December 31, 2024, and $77.2 million at December 31, 2023, held by consolidated investment products | 2712.9 | 2143.8 |
| Cash and cash equivalents at end of period, including $49.1 million at September 30, 2025, and $55.1 million at September 30, 2024, held by consolidated investment products | $3683.9 | $3228.6 |

---

The accompanying notes are an integral part of these statements.

------

**UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

**(shares in thousands; dollars in millions)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** |
| | **Common<br>shares<br>outstanding** | **Common<br>stock** | **Additional<br>capital in<br>excess of<br>par value** | **Retained<br>earnings** | **AOCI**<sup>(1)</sup> | **Total <br>stockholders'<br>equity attributable to T. Rowe Price Group, Inc.** | **Non-controlling interests in consolidated entities** | **Total permanent stockholders' equity** | **Redeemable non-controlling interests** |
| Balances at June 30, 2025 | 219902 | $44.0 | $99.8 | $10461.3 | $(44.6) | $10560.5 | $153.3 | $10713.8 | $1099.1 |
| Net income (loss) |  |  |  | 646.1 |  | 646.1 | 16.8 | 662.9 | 40.4 |
| Other comprehensive income (loss), net of tax |  |  |  |  | (1.9) | (1.9) |  | (1.9) | (2.8) |
| Dividends declared ($1.27 per share) |  |  |  | (283.8) |  | (283.8) |  | (283.8) |  |
| Common stock-based compensation plans activity: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Shares issued upon option exercises | 232 |  | 14.4 |  |  | 14.4 |  | 14.4 |  |
| &nbsp;&nbsp;Net shares issued upon vesting of restricted stock units | 8 |  | (0.4) |  |  | (0.4) |  | (0.4) |  |
| &nbsp;&nbsp;Stock-based compensation expense |  |  | 37.3 |  |  | 37.3 |  | 37.3 |  |
| &nbsp;&nbsp;Restricted stock units issued as dividend equivalents |  |  | 0.3 | (0.3) |  |  |  |  |  |
| Common shares repurchased | (1458) | (0.3) | (151.4) | (6.0) |  | (157.7) |  | (157.7) |  |
| Net contributions to non-controlling interests in consolidated entities |  |  |  |  |  |  | (0.1) | (0.1) |  |
| Net subscriptions into T. Rowe Price investment products |  |  |  |  |  |  |  |  | 290.1 |
| Net deconsolidations of T. Rowe Price investment products |  |  |  |  |  |  |  |  | (441.9) |
| Balances at September 30, 2025 | 218684 | $43.7 | $— | $10817.3 | $(46.5) | $10814.5 | $170.0 | $10984.5 | $984.9 |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** |
| | **Common<br>shares<br>outstanding** | **Common<br>stock** | **Additional<br>capital in<br>excess of<br>par value** | **Retained<br>earnings** | **AOCI**<sup>(1)</sup> | **Total <br>stockholders'<br>equity attributable to T. Rowe Price Group, Inc.** | **Non-controlling interests in consolidated entities** | **Total permanent stockholders' equity** | **Redeemable non-controlling interests** |
| Balances at June 30, 2024 | 222612 | $44.5 | $368.8 | $9564.6 | $(49.2) | $9928.7 | $205.3 | $10134.0 | $689.0 |
| Net income (loss) |  |  |  | 603.0 |  | 603.0 | (2.0) | 601.0 | 37.4 |
| Other comprehensive income (loss), net of tax |  |  |  |  | 9.7 | 9.7 |  | 9.7 | 7.4 |
| Dividends declared ($1.24 per share) |  |  |  | (282.2) |  | (282.2) |  | (282.2) |  |
| Common stock-based compensation plans activity: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Shares issued upon option exercises | 187 |  | 12.1 |  |  | 12.1 |  | 12.1 |  |
| &nbsp;&nbsp;Net shares issued upon vesting of restricted stock units | 8 |  | (0.2) |  |  | (0.2) |  | (0.2) |  |
| &nbsp;&nbsp;Stock-based compensation expense |  |  | 49.5 |  |  | 49.5 |  | 49.5 |  |
| &nbsp;&nbsp;Restricted stock units issued as dividend equivalents |  |  | 0.1 | (0.1) |  |  |  |  |  |
| Common shares repurchased | (664) | (0.1) | (71.2) |  |  | (71.3) |  | (71.3) |  |
| Net contributions to non-controlling interests in consolidated entities |  |  |  |  |  |  | 0.1 | 0.1 |  |
| Net subscriptions into T. Rowe Price investment products |  |  |  |  |  |  |  |  | 190.2 |
| Net deconsolidations of T. Rowe Price investment products |  |  |  |  |  |  |  |  | (160.6) |
| Balances at September 30, 2024 | 222143 | $44.4 | $359.1 | $9885.3 | $(39.5) | $10249.3 | $203.4 | $10452.7 | $763.4 |

---

<sup>(1)</sup> *Accumulated other comprehensive income.*

The accompanying notes are an integral part of these statements.

------

**UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

**(shares in thousands; dollars in millions)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** |
| | **Common<br>shares<br>outstanding** | **Common<br>stock** | **Additional<br>capital in<br>excess of<br>par value** | **Retained<br>earnings** | **AOCI**<sup>(1)</sup> | **Total <br>stockholders'<br>equity attributable to T. Rowe Price Group, Inc.** | **Non-controlling interests in consolidated entities** | **Total permanent stockholders' equity** | **Redeemable non-controlling interests** |
| Balances at December 31, 2024 | 222966 | $44.6 | $311.9 | $10040.6 | $(51.7) | $10345.4 | $160.7 | $10506.1 | $944.0 |
| Net income (loss) |  |  |  | 1641.8 |  | 1641.8 | 14.9 | 1656.7 | 105.9 |
| Other comprehensive income (loss), net of tax |  |  |  |  | 5.2 | 5.2 |  | 5.2 | 8.2 |
| Dividends declared ($3.81 per share) |  |  |  | (858.7) |  | (858.7) |  | (858.7) |  |
| Common stock-based compensation plans activity: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Shares issued upon option exercises | 496 | 0.1 | 31.5 |  |  | 31.6 |  | 31.6 |  |
| &nbsp;&nbsp;Restricted shares issued, net of shares withheld for taxes | 8 |  | (0.2) |  |  | (0.2) |  | (0.2) |  |
| &nbsp;&nbsp;Net shares issued upon vesting of restricted stock units | 23 |  | (1.0) |  |  | (1.0) |  | (1.0) |  |
| &nbsp;&nbsp;Stock-based compensation expense |  |  | 134.2 |  |  | 134.2 |  | 134.2 |  |
| &nbsp;&nbsp;Restricted stock units issued as dividend equivalents |  |  | 0.4 | (0.4) |  |  |  |  |  |
| Common shares repurchased | (4809) | (1.0) | (476.8) | (6.0) |  | (483.8) |  | (483.8) |  |
| Net distributions to non-controlling interests in consolidated entities |  |  |  |  |  |  | (5.6) | (5.6) |  |
| Net subscriptions into T. Rowe Price investment products |  |  |  |  |  |  |  |  | 549.8 |
| Net deconsolidations of T. Rowe Price investment products |  |  |  |  |  |  |  |  | (623.0) |
| Balances at September 30, 2025 | 218684 | $43.7 | $— | $10817.3 | $(46.5) | $10814.5 | $170.0 | $10984.5 | $984.9 |
|  | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** |
|  | **Common<br>shares<br>outstanding** | **Common<br>stock** | **Additional<br>capital in<br>excess of<br>par value** | **Retained<br>earnings** | **AOCI**<sup>(1)</sup> | **Total <br>stockholders'<br>equity attributable to T. Rowe Price Group, Inc.** | **Non-controlling interests in consolidated entities** | **Total permanent stockholders' equity** | **Redeemable non-controlling interests** |
| Balances at December 31, 2023 | 223938 | $44.8 | $431.7 | $9076.1 | $(47.5) | $9505.1 | $192.0 | $9697.1 | $594.1 |
| Net income (loss) |  |  |  | 1660.2 |  | 1660.2 | 8.8 | 1669.0 | 58.9 |
| Other comprehensive income (loss), net of tax |  |  |  |  | 8.0 | 8.0 |  | 8.0 | 6.2 |
| Dividends declared ($3.72 per share) |  |  |  | (850.7) |  | (850.7) |  | (850.7) |  |
| Common stock-based compensation plans activity: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Shares issued upon option exercises | 482 | 0.1 | 30.4 |  |  | 30.5 |  | 30.5 |  |
| &nbsp;&nbsp;Restricted shares issued, net of shares withheld for taxes | 7 |  | (0.3) |  |  | (0.3) |  | (0.3) |  |
| &nbsp;&nbsp;Net shares issued upon vesting of restricted stock units | 64 |  | (2.0) |  |  | (2.0) |  | (2.0) |  |
| &nbsp;&nbsp;Stock-based compensation expense |  |  | 162.2 |  |  | 162.2 |  | 162.2 |  |
| &nbsp;&nbsp;Restricted stock units issued as dividend equivalents |  |  | 0.3 | (0.3) |  |  |  |  |  |
| Common shares repurchased | (2348) | (0.5) | (263.2) |  |  | (263.7) |  | (263.7) |  |
| Net contributions to non-controlling interests in consolidated entities |  |  |  |  |  |  | 2.6 | 2.6 |  |
| Net subscriptions into T. Rowe Price investment products |  |  |  |  |  |  |  |  | 361.0 |
| Net deconsolidations of T. Rowe Price investment products |  |  |  |  |  |  |  |  | (256.8) |
| Balances at September 30, 2024 | 222143 | $44.4 | $359.1 | $9885.3 | $(39.5) | $10249.3 | $203.4 | $10452.7 | $763.4 |

---

<sup>(1)</sup> *Accumulated other comprehensive income.*

The accompanying notes are an integral part of these statements.

------

**<u>NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**NOTE 1 – THE COMPANY AND BASIS OF PREPARATION.**

T. Rowe Price Group, Inc. derives its consolidated revenues and net income primarily from investment advisory services that its subsidiaries provide to individual and institutional investors that invest in a broad range of investment solutions across equity, fixed income, multi-asset, and alternative capabilities. We also provide certain investment advisory clients with related administrative services, including distribution, mutual fund transfer agent, accounting, and shareholder services; participant recordkeeping and transfer agent services for defined contribution retirement plans; brokerage; trust services; and non-discretionary advisory services.

The investment solutions are provided in a number of vehicles including the T. Rowe Price U.S. mutual funds ("U.S. mutual funds"), subadvised funds, separately managed accounts, collective investment trusts, exchange-traded funds, and other sponsored products. The other sponsored products include: open-ended investment products offered to investors outside the U.S., products offered through variable annuity life insurance plans in the U.S., affiliated private investment funds, business development companies, an interval fund, and collateralized loan obligations.

Investment advisory fees depend largely on the total value and composition of assets under our management. Accordingly, fluctuations in financial markets and in the composition of assets under management impact our revenues and results of operations.

***<u>BASIS OF PRESENTATION.</u>***

These unaudited consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. These principles require the use of estimates and reflect all adjustments that are, in the opinion of management, necessary for a fair statement of our results for the interim periods presented. All such adjustments are of a normal recurring nature. Actual results may vary from our estimates. We are reporting performance-based advisory fees in a separate line of the consolidated income statement to increase transparency, therefore, investment advisory fees for prior periods were recast to reflect the new presentation and ensure comparability.

The unaudited financial information contained in these consolidated financial statements should be read in conjunction with the consolidated financial statements contained in our 2024 Annual Report.

***<u>NEWLY ENACTED U.S. LEGISLATION.</u>***

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was enacted in the U.S. The OBBBA contains significant changes and modifications to federal and international tax provisions including 100% bonus depreciation and domestic research cost expensing. We continue evaluating the impact of the legislation on our estimated annual effective tax rate. We believe that the impact of the OBBBA's provisions will not be material to our financial position and results of operations.

***<u>NEWLY ISSUED BUT NOT YET ADOPTED ACCOUNTING GUIDANCE.</u>***

In December 2023, the FASB issued Accounting Standards Update No. 2023-09 - *Income Taxes (Topic 740) - Improvements to Income Tax Disclosures,* which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation as well as disclosure of income taxes paid disaggregated by jurisdiction. This amendment is effective for our 2025 annual disclosures. The additional disclosure requirements will not have a material impact on our consolidated financial statements.

In November 2024, the FASB issued Accounting Standards Update No. 2024-03 *- Income Statement- Reporting Comprehensive Income- Expense Disaggregation Disclosures (Subtopic 220-4): Disaggregation of Income Statement Expenses*, which requires disclosures of additional information and disaggregation of certain expenses included in the income statement. The guidance is effective for the firm on January 1, 2027, and allows for either a prospective or retrospective approach on adoption. We are currently evaluating the impact that the adoption will have on our financial statements and have not yet determined our transition approach.

------

We have considered all other newly issued accounting guidance that is applicable to our operations and the preparation of our unaudited consolidated statements, including those we have not yet adopted. We do not believe that any such guidance has or will have a material effect on our financial position or results of operations.

**NOTE 2 – INFORMATION ABOUT RECEIVABLES, REVENUES, AND SERVICES.**

Net revenues earned in the three- and nine-month periods ended September 30, 2025 and 2024, are included in the table below along with details of investment advisory revenues by underlying asset class. We also included average assets under management by asset class, on which we earn investment advisory fees.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Nine months ended** | **Nine months ended** |
| (in millions) | **9/30/2025** | **9/30/2024** | **9/30/2025** | **9/30/2024** |
| Investment advisory fees |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | $1011.8 | $978.5 | $2894.6 | $2858.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income, including money market | 110.1 | 104.1 | 319.2 | 304.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-asset | 492.1 | 465.8 | 1402.7 | 1340.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Alternatives | 84.7 | 78.9 | 248.2 | 229.2 |
| Total investment advisory fees | $1698.7 | $1627.3 | $4864.7 | $4732.5 |
| Performance-based advisory fees | 6.4 | 5.6 | 23.2 | 40.0 |
| Capital allocation-based income (loss) | 42.0 | 4.6 | 40.4 | 51.8 |
| Administrative, distribution, services, and other fees | 146.4 | 148.1 | 452.4 | 444.8 |
| Net revenues | $1893.5 | $1785.6 | $5380.7 | $5269.1 |
| Average AUM (in billions): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | $865.8 | $813.1 | $825.7 | $791.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income, including money market | 203.8 | 183.3 | 197.8 | 175.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-asset | 597.7 | 542.3 | 566.8 | 519.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Alternatives | 55.7 | 50.8 | 54.1 | 49.0 |
| Average AUM | $1723.0 | $1589.5 | $1644.4 | $1536.2 |

---

Total net revenues earned from sponsored investment products totaled $1,594.2 million and $1,486.5 million for the three months ended September 30, 2025 and 2024, respectively. Total net revenues earned during the nine months ended September 30, 2025 and 2024 aggregate $4,500.7 million and $4,359.5 million, respectively. Accounts receivable from these products totaled $628.2 million at September 30, 2025 and $602.0 million at December 31, 2024.

Investors that we serve are primarily domiciled in the U.S.; investment advisory clients outside the U.S. account for 8.7% at September 30, 2025, 8.7% at June 30, 2025, and 8.8% at December 31, 2024 of our assets under management.

------

**NOTE 3 – INVESTMENTS.**

The carrying values of our investments that are not consolidated investment products are as follows:

---

| | | |
|:---|:---|:---|
| (in millions) | **9/30/2025** | **12/31/2024** |
| Investments held at fair value |  |  |
| &nbsp;&nbsp;&nbsp;T. Rowe Price investment products |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discretionary investments | $572.4 | $258.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seed capital | 345.7 | 262.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred compensation liabilities economic hedges | 1060.2 | 992.8 |
| &nbsp;&nbsp;&nbsp;Investment partnerships and other investments | 180.3 | 62.6 |
| &nbsp;&nbsp;&nbsp;Investments in affiliated collateralized loan obligations | 3.8 | 6.3 |
| Equity method investments |  |  |
| &nbsp;&nbsp;&nbsp;T. Rowe Price investment products |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discretionary investments | 20.2 | 60.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seed capital | 37.5 | 128.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred compensation liabilities economic hedges | 50.6 | 88.4 |
| &nbsp;&nbsp;&nbsp;Investment in UTI Asset Management Company Limited (India) | 165.7 | 173.5 |
| &nbsp;&nbsp;&nbsp;Investments in affiliated private investment funds - carried interest | 413.1 | 426.9 |
| &nbsp;&nbsp;&nbsp;Investments in affiliated private investment funds - seed/co-investment | 292.7 | 269.9 |
| &nbsp;&nbsp;&nbsp;Investment partnerships and other investments | 189.4 | 162.1 |
| Held to maturity |  |  |
| &nbsp;&nbsp;&nbsp;Investments in affiliated collateralized loan obligations | 34.4 | 61.1 |
| &nbsp;&nbsp;&nbsp;Certificates of deposit | 50.4 | 44.7 |
| &nbsp;&nbsp; U.S. Treasury note | 1.0 | 1.0 |
| Total | $3417.4 | $3000.5 |

---

The investment partnerships held at fair value are valued using net asset value ("NAV") per share as a practical expedient. Our interests in these partnerships are generally not redeemable and are subject to significant transferability restrictions. The underlying investments of these partnerships have contractual terms through 2029, though we may receive distributions of liquidating assets over a longer term. The investment strategies of these partnerships include growth equity, buyout, venture capital, and real estate.

During the three- and nine-months ended September 30, 2025, net gains on investments included $80.8 million and $165.9 million, respectively, of net unrealized gains related to investments carried at fair value that were still held at September 30, 2025. For the same periods of 2024, net gains on investments included $44.3 million and $129.3 million, respectively, of net unrealized gains related to investments carried at fair value that were still held at September 30, 2024.

During the nine months ended September 30, 2025 and 2024, certain T. Rowe Price investment products in which we provided initial seed capital at the time of formation were deconsolidated, as we no longer had a controlling interest. Depending on our ownership interest, we report our residual interests in these T. Rowe Price investment products as either an equity method investment or an investment held at fair value. The net impact on our unaudited consolidated balance sheets and statements of income as of the dates the products were deconsolidated is detailed below.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Nine months ended** | **Nine months ended** |
| (in millions) | **9/30/2025** | **9/30/2024** | **9/30/2025** | **9/30/2024** |
| Net increase (decrease) in assets of consolidated investment products | $(552.8) | $(371.7) | $(1156.9) | $(643.5) |
| Net increase (decrease) in liabilities of consolidated investment products | $(17.6) | $(14.6) | $(42.9) | $(19.5) |
| Net increase (decrease) in redeemable non-controlling interests | $(441.9) | $(160.6) | $(623.0) | $(256.8) |

---

------

**<u>VARIABLE INTEREST ENTITIES.</u>**

Our fair value and equity method investments at September 30, 2025 and December 31, 2024 include interests in variable interest entities that we do not consolidate as we are not deemed the primary beneficiary. Our maximum risk of loss related to our involvement with these entities is as follows:

---

| | | |
|:---|:---|:---|
| (in millions) | **9/30/2025** | **12/31/2024** |
| Investment carrying values | $1040.2 | $955.9 |
| Unfunded capital commitments | 221.4 | 202.5 |
| Accounts receivable | 94.9 | 96.2 |
|  | $1356.5 | $1254.6 |

---

We have unfunded capital commitments, totaling $221.4 million at September 30, 2025 and $202.5 million at December 31, 2024, related primarily to the affiliated private investment funds and the investment partnerships in which we have an existing investment. In addition to such amounts, a percentage of prior distributions may be recalled under certain circumstances.

Investments in affiliated private investment funds - carried interest represent interests in the general partners of affiliated private investment funds that are entitled to a disproportionate allocation of income, also known as carried interest. The entities that hold these interests ("carried interest entities") are considered variable interest entities and are consolidated as T. Rowe Price is determined to be the primary beneficiary. The total assets, liabilities and non-controlling interests of these carried interest entities as of September 30, 2025 and December 31, 2024, are as follows:

---

| | | |
|:---|:---|:---|
| (in millions) | **9/30/2025** | **12/31/2024** |
| Assets | $455.9 | $467.7 |
| Liabilities | $0.8 | $0.4 |
| Non-controlling interest | $170.0 | $160.7 |

---

**<u>INVESTMENTS IN AFFILIATED COLLATERALIZED LOAN OBLIGATIONS.</u>**

There is debt associated with our investments in affiliated collateralized loan obligations ("CLOs"). The debt relates to outstanding repurchase agreements of €29.3 million at September 30, 2025 and €56.9 million at December 31, 2024 (equivalent to $34.4 million at September 30, 2025 and $59.1 million at December 31, 2024 at the respective EUR spot rates) that are collateralized by the CLO investments and reported in accounts payable and accrued expenses in our consolidated balance sheets. These repurchase agreements bear interest at rates based on EURIBOR plus the initial margin, which equals all-in rates ranging from 2.02% to 10.89% as of September 30, 2025. The debt matures on various dates through 2035 or if the investments are paid back in full or cancelled, whichever is sooner.

**NOTE 4 – FAIR VALUE MEASUREMENTS.**

We determine the fair value of our cash equivalents and certain investments held at fair value using the following broad levels of inputs as defined by related accounting standards:

Level 1 – quoted prices in active markets for identical financial instruments accessible at the reporting date.

Level 2 – observable inputs other than Level 1 quoted prices including, but not limited to, quoted prices for similar financial instruments in active markets, quoted prices for identical or similar financial instruments in inactive markets, interest rates and yield curves, implied volatilities, and credit spreads. These inputs are based on market data obtained from independent sources.

Level 3 – unobservable inputs reflecting our own assumptions based on the best information available. The inputs into the determination of fair value require significant management judgment or estimation. Investments in this category generally include investments for which there is not an actively-traded market.

------

These levels are not necessarily an indication of the risk or liquidity associated with our investments. The following table summarizes our investments and liabilities that are recognized in our unaudited consolidated balance sheets using fair value measurements determined based on the differing levels of inputs. This table excludes investments held by the consolidated investment products, which are presented separately in our unaudited consolidated balance sheets and are detailed in Note 5.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **9/30/2025** | **9/30/2025** | **9/30/2025** | **12/31/2024** | **12/31/2024** | **12/31/2024** |
| (in millions) | **Level 1** | **Level 2** | **Level 3** | **Level 1** | **Level 2** | **Level 3** |
| T. Rowe Price investment products |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash equivalents held in money market funds | $3223.3 | $— | $— | $2309.8 | $— | $— |
| &nbsp;&nbsp;&nbsp;Discretionary investments | 572.4 |  |  | 258.8 |  |  |
| &nbsp;&nbsp;&nbsp;Seed capital | 288.2 | 57.5 |  | 209.4 | 53.4 |  |
| &nbsp;&nbsp;&nbsp;Deferred compensation liabilities economic hedges | 1060.2 |  |  | 992.8 |  |  |
| Other investments | 1.0 |  | 71.5 | 0.1 |  |  |
| Investments in affiliated collateralized loan obligations |  | 3.8 |  |  | 6.3 |  |
| Total | $5145.1 | $61.3 | $71.5 | $3770.9 | $59.7 | $— |

---

The fair value hierarchy level table above does not include the investment partnerships and other investments for which fair value is estimated using their NAV per share as a practical expedient or using the measurement alternative. The carrying value of these investments as disclosed in Note 3 were $107.8 million at September 30, 2025, and $62.5 million at December 31, 2024.

The Level 3 investments' fair value is derived from inputs that are unobservable and that reflect our own determinations about the assumptions that market participants would use in pricing the investments, including assumptions about risk. These inputs are developed based on our data, which is adjusted if information indicates that market participants would use different assumptions. For the nine months ended September 30, 2025, the change in Level 3 fair values were solely attributable to the purchases of new investments and there were no transfers into or out of Level 3. The following table provides information about the significant Level 3 inputs:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair value measurements as of September 30, 2025** | **Fair value measurements as of September 30, 2025** | **Fair value measurements as of September 30, 2025** | **Fair value measurements as of September 30, 2025** |
| (in millions) | **Fair value** | **Valuation techniques** | **Unobservable inputs** | **Interest rate input** |
| Other investments | $71.5 | Market Yield (Comparables) | Yield | 8.99% |

---

**NOTE 5 – CONSOLIDATED INVESTMENT PRODUCTS.**

The investment products that we consolidate in our consolidated financial statements are generally those products we provided initial seed capital at the time of their formation and have a controlling interest. Our U.S. mutual funds and certain other products are considered voting interest entities, while those regulated outside the U.S. are considered variable interest entities.

The following table details the net assets of the consolidated investment products:

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **9/30/2025** | **9/30/2025** | **9/30/2025** | **12/31/2024** | **12/31/2024** | **12/31/2024** |
| (in millions) | **Voting <br>interest entities** | **Variable interest entities** | **Total** | **Voting <br>interest entities** | **Variable interest entities** | **Total** |
| Cash and cash equivalents<sup>(1)</sup> | $1.9 | $47.2 | $49.1 | $7.2 | $55.9 | $63.1 |
| Investments<sup>(2)</sup> | 174.3 | 1531.1 | 1705.4 | 470.8 | 1465.4 | 1936.2 |
| Other assets | 1.7 | 21.5 | 23.2 | 10.4 | 34.3 | 44.7 |
| Total assets | 177.9 | 1599.8 | 1777.7 | 488.4 | 1555.6 | 2044.0 |
| Liabilities | 1.0 | 21.7 | 22.7 | 15.9 | 46.2 | 62.1 |
| Net assets | $176.9 | $1578.1 | $1755.0 | $472.5 | $1509.4 | $1981.9 |
| Attributable to T. Rowe Price Group, Inc. | $132.4 | $637.7 | $770.1 | $348.5 | $689.4 | $1037.9 |
| Attributable to redeemable non-controlling interests | 44.5 | 940.4 | 984.9 | 124.0 | 820.0 | 944.0 |
|  | $176.9 | $1578.1 | $1755.0 | $472.5 | $1509.4 | $1981.9 |

---

<sup>(1)</sup> *Cash and cash equivalents includes $1.4 million at September 30, 2025, and $4.9 million at December 31, 2024, of investments in T. Rowe Price money market mutual funds.*

<sup>(2)</sup> *Investments include $41.5 million at September 30, 2025, and $9.3 million at December 31, 2024, of other T. Rowe Price investment products.*

Although we can generally redeem our net interest in the consolidated investment products at any time, we cannot directly access or sell the assets held by these products to obtain cash for general operations. Additionally, the assets of these investment products are not available to our general creditors.

Since third-party investors in these investment products have no recourse to our credit, our overall risk related to the net assets of consolidated investment products is limited to valuation changes associated with our net interest. However, we are required to recognize the valuation changes associated with all underlying investments held by these products in our consolidated statements of income and disclose the portion attributable to unrelated third-party investors as net income attributable to redeemable non-controlling interests.

The operating results of the consolidated investment products for the three- and nine-months ended September 30, 2025 and 2024, are reflected in our unaudited consolidated statements of income as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** |
| | **9/30/2025** | **9/30/2025** | **9/30/2025** | **9/30/2024** | **9/30/2024** | **9/30/2024** |
| (in millions) | **Voting <br>interest entities** | **Variable interest entities** | **Total** | **Voting <br>interest entities** | **Variable interest entities** | **Total** |
| Operating expenses reflected in net operating income | $(0.1) | $(2.1) | $(2.2) | $(0.5) | $(1.9) | $(2.4) |
| Net investment income (loss) reflected in non-operating income (loss) | 7.1 | 65.5 | 72.6 | 27.3 | 58.6 | 85.9 |
| Impact on income before taxes | $7.0 | $63.4 | $70.4 | $26.8 | $56.7 | $83.5 |
| Net income (loss) attributable to T. Rowe Price Group, Inc. | $5.4 | $24.6 | $30.0 | $19.2 | $26.9 | $46.1 |
| Net income (loss) attributable to redeemable non-controlling interests | 1.6 | 38.8 | 40.4 | 7.6 | 29.8 | 37.4 |
|  | $7.0 | $63.4 | $70.4 | $26.8 | $56.7 | $83.5 |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine months ended** | **Nine months ended** | **Nine months ended** | **Nine months ended** | **Nine months ended** | **Nine months ended** |
| | **9/30/2025** | **9/30/2025** | **9/30/2025** | **9/30/2024** | **9/30/2024** | **9/30/2024** |
| (in millions) | **Voting <br>interest entities** | **Variable interest entities** | **Total** | **Voting <br>interest entities** | **Variable interest entities** | **Total** |
| Operating expenses reflected in net operating income | $(0.4) | $(6.7) | $(7.1) | $(2.0) | $(5.3) | $(7.3) |
| Net investment income (loss) reflected in non-operating income (loss) | 24.6 | 158.5 | 183.1 | 57.0 | 109.7 | 166.7 |
| Impact on income before taxes | $24.2 | $151.8 | $176.0 | $55.0 | $104.4 | $159.4 |
| Net income (loss) attributable to T. Rowe Price Group, Inc. | $17.8 | $52.3 | $70.1 | $42.0 | $58.5 | $100.5 |
| Net income (loss) attributable to redeemable non-controlling interests | 6.4 | 99.5 | 105.9 | 13.0 | 45.9 | 58.9 |
|  | $24.2 | $151.8 | $176.0 | $55.0 | $104.4 | $159.4 |

---

The operating expenses of the consolidated investment products are reflected in general, administrative and other expenses. In preparing our unaudited consolidated financial statements, we eliminated operating expenses of $0.8 million and $1.3 million for the three months ended September 30, 2025 and 2024, respectively, against the investment advisory and administrative fees earned from these products. Operating expenses eliminated for the nine months ended September 30, 2025 and 2024, were $3.6 million and $3.0 million, respectively. The net investment income (loss) reflected in non-operating income (loss) includes dividend and interest income as well as realized and unrealized gains and losses on the underlying securities held by the consolidated investment products.

The table below details the impact of these consolidated investment products on the individual lines of our unaudited consolidated statements of cash flows for the nine months ended September 30, 2025 and 2024.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine months ended** | **Nine months ended** | **Nine months ended** | **Nine months ended** | **Nine months ended** | **Nine months ended** |
| | **9/30/2025** | **9/30/2025** | **9/30/2025** | **9/30/2024** | **9/30/2024** | **9/30/2024** |
| (in millions) | **Voting <br>interest entities** | **Variable interest entities** | **Total** | **Voting <br>interest entities** | **Variable interest entities** | **Total** |
| Net cash provided by (used in) operating activities | $(205.7) | $(440.8) | $(646.5) | $(170.5) | $(182.3) | $(352.8) |
| Net cash provided by (used in) investing activities | 0.7 | (36.5) | (35.8) | (14.7) | (1.0) | (15.7) |
| Net cash provided by (used in) financing activities | 199.7 | 465.2 | 664.9 | 165.3 | 180.6 | 345.9 |
| Effect of exchange rate changes on cash and cash equivalents of consolidated investment products |  | 3.4 | 3.4 |  | 0.5 | 0.5 |
| Net change in cash and cash equivalents during period | (5.3) | (8.7) | (14.0) | (19.9) | (2.2) | (22.1) |
| Cash and cash equivalents at beginning of year | 7.2 | 55.9 | 63.1 | 25.7 | 51.5 | 77.2 |
| Cash and cash equivalents at end of period | $1.9 | $47.2 | $49.1 | $5.8 | $49.3 | $55.1 |

---

For the nine months ended September 30, 2025, the net cash provided by (used in) financing activities includes $134.8 million of net subscriptions we made into the consolidated investment products, net of dividends received. For the nine months ended September 30, 2024, the net cash provided by (used in) financing activities included $15.3 million of net redemptions we made from the consolidated investment products. These cash flows were eliminated in consolidation.

**<u>FAIR VALUE MEASUREMENTS.</u>**

We determine the fair value of investments held by consolidated investment products using the following broad levels of inputs as defined by related accounting standards:

Level 1 – quoted prices in active markets for identical financial instruments accessible at the reporting date.

Level 2 – observable inputs other than Level 1 quoted prices including, but not limited to, quoted prices for similar financial instruments in active markets, quoted prices for identical or similar financial instruments in

------

inactive markets, interest rates and yield curves, implied volatilities, and credit spreads. These inputs are based on market data obtained from independent sources.

Level 3 – unobservable inputs reflecting our own assumptions based on the best information available. The inputs into the determination of fair value require significant management judgment or estimation. Investments in this category generally include investments for which there is not an actively-traded market. There are no Level 3 investments at September 30, 2025 and December 31, 2024.

These levels are not necessarily an indication of the risk or liquidity associated with these investment holdings. The following table summarizes the investment holdings held by our consolidated investment products using fair value measurements determined based on the differing levels of inputs.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **9/30/2025** | **9/30/2025** | **12/31/2024** | **12/31/2024** |
| (in millions) | **Level 1** | **Level 2** | **Level 1** | **Level 2** |
| Assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash equivalents | $1.7 | $— | $6.3 | $— |
| &nbsp;&nbsp;&nbsp;Equity securities | 493.7 | 378.5 | 452.3 | 285.4 |
| &nbsp;&nbsp;&nbsp;Fixed income securities |  | 813.5 |  | 1173.5 |
| &nbsp;&nbsp;&nbsp;Other investments | 0.7 | 19.0 | 1.6 | 23.4 |
|  | $496.1 | $1211.0 | $460.2 | $1482.3 |
| Liabilities | $(0.2) | $(6.0) | $(1.7) | $(14.5) |

---

**NOTE 6 - GOODWILL AND INTANGIBLE ASSETS.**

Goodwill and intangible assets consist of the following:

---

| | | |
|:---|:---|:---|
| (in millions) | **9/30/2025** | **12/31/2024** |
| Goodwill | $2642.8 | $2642.8 |
| Indefinite-lived intangible asset - trade name | 86.0 | 86.0 |
| Indefinite-lived intangible asset - investment advisory agreement | 62.3 | 65.6 |
| Definite-lived intangible assets - investment advisory agreements | 146.3 | 216.5 |
| Total | $2937.4 | $3010.9 |

---

Amortization and impairment expense for the definite-lived intangible assets was $22.3 million and $70.2 million for the three- and nine-months ended September 30, 2025, respectively. For the three- and nine-months ended September 30, 2024, amortization and impairment expense for the definite-lived intangible assets was $28.3 million and $81.0 million, respectively. Estimated amortization expense for the definite-lived intangible assets for the five succeeding years is as follows:

---

| | |
|:---|:---|
| (in millions) |  |
| &nbsp;&nbsp;Remaining 2025 | $20.4 |
| &nbsp;&nbsp;&nbsp;2026 | $54.6 |
| &nbsp;&nbsp;&nbsp;2027 | $39.1 |
| &nbsp;&nbsp;&nbsp;2028 | $11.8 |
| &nbsp;&nbsp;&nbsp;2029 | $8.8 |

---

We evaluate the carrying amount of goodwill and indefinite-lived intangible assets for possible impairment on an annual basis in the fourth quarter or if triggering events occur that require us to evaluate for impairment earlier. No triggering events arose during the three months ended September 30, 2025.

------

**NOTE 7 – LONG-TERM INCENTIVE COMPENSATION.**

**<u>STOCK OPTIONS.</u>**

The following table summarizes the status of, and changes in, our stock options during the nine months ended September 30, 2025:

---

| | | |
|:---|:---|:---|
| | **Options** | **Weighted-**<br>**average**<br>**exercise**<br>**price** |
| Outstanding at December 31, 2024 | 661377 | $73.76 |
| Exercised | (642149) | $73.89 |
| Expired | (1560) | $79.71 |
| Outstanding and exercisable at September 30, 2025 | 17668 | $68.49 |

---

**<u>RESTRICTED STOCK UNITS.</u>**

The following table summarizes the status of, and changes in, our nonvested restricted stock units during the nine months ended September 30, 2025:

---

| | | |
|:---|:---|:---|
| | **Restricted**<br>**stock**<br>**units** | **Weighted-average**<br>**fair value** |
| Nonvested at December 31, 2024 | 6001579 | $124.73 |
| Time-based grants | 29447 | $100.45 |
| Vested | (33281) | $126.38 |
| Forfeited | (283954) | $126.82 |
| Nonvested at September 30, 2025 | 5713791 | $124.49 |

---

Nonvested at September 30, 2025 includes performance-based restricted stock units of 359,941. These nonvested performance-based restricted stock units include 102,345 units for which the performance period has lapsed, and the performance threshold has been met.

**<u>FUTURE STOCK-BASED COMPENSATION EXPENSE.</u>**

The following table presents the compensation expense to be recognized over the remaining vesting periods of the stock-based awards outstanding at September 30, 2025. Estimated future compensation expense will change to reflect future grants of restricted stock awards and units, future option grants, changes in the probability of performance thresholds being met, and adjustments for actual forfeitures.

---

| | |
|:---|:---|
| (in millions) |  |
| Fourth quarter 2025 | $42.9 |
| 2026 | 96.3 |
| 2027 through 2030 | 64.9 |
| Total | $204.1 |

---

------

**<u>RESTRICTED FUND UNITS.</u>**

Below is a roll forward of the restricted fund units liability, which is reported in deferred compensation liabilities on the unaudited consolidated balance sheet.

---

| | |
|:---|:---|
| (in millions) |  |
| Balance at December 31, 2024 | $14.7 |
| Amortization of grant date value | 32.8 |
| Amortization of market appreciation (depreciation) | 5.8 |
| Balance at September 30, 2025 | $53.3 |

---

The following table presents the compensation expense to be recognized over the remaining vesting periods of the restricted fund units outstanding at September 30, 2025. Estimated future compensation expense will change to reflect future grants, changes in the market value of the restricted fund units, which is based on selected hypothetical investments, and adjustments for actual forfeitures. The grants outstanding will vest by 2029.

---

| | |
|:---|:---|
| (in millions) |  |
| Fourth quarter 2025 | $9.9 |
| 2026 | 24.7 |
| 2027 through 2029 | 23.3 |
| Total | $57.9 |

---

**NOTE 8 – EARNINGS PER SHARE CALCULATIONS.**

The following table presents the reconciliation of net income attributable to T. Rowe Price Group, Inc. to net income allocated to our common stockholders and the weighted-average shares that are used in calculating the basic and diluted earnings per share on our common stock. Weighted-average common shares outstanding assuming dilution reflects the potential dilution, determined using the treasury stock method, that could occur if outstanding stock options were exercised and non-participating stock awards vested. No outstanding stock options had an anti-dilutive impact on the diluted earnings per common share calculation in the periods presented.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Nine months ended** | **Nine months ended** |
| (in millions) | **9/30/2025** | **9/30/2024** | **9/30/2025** | **9/30/2024** |
| Net income attributable to T. Rowe Price Group, Inc. | $646.1 | $603.0 | $1641.8 | $1660.2 |
| Less: net income allocated to outstanding restricted stock and stock unit holders | 14.7 | 15.5 | 39.5 | 44.2 |
| Net income allocated to common stockholders | $631.4 | $587.5 | $1602.3 | $1616.0 |
| Weighted-average common shares |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Outstanding | 219.4 | 222.3 | 220.6 | 223.0 |
| &nbsp;&nbsp;&nbsp;Outstanding assuming dilution | 219.7 | 222.8 | 220.9 | 223.5 |

---

------

**NOTE 9 – OTHER COMPREHENSIVE INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS.**

The changes in each component of accumulated other comprehensive income (loss), including reclassification adjustments for three months ended September 30, 2025 and 2024 are presented in the table below.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** |
| (in millions) | **Equity method investments** | **Consolidated investment products - variable interest entities** | **Total currency translation adjustments** | **Equity method investments** | **Consolidated investment products - variable interest entities** | **Total currency translation adjustments** |
| Balances at beginning of period | $(52.5) | $7.9 | $(44.6) | $(51.5) | $2.3 | $(49.2) |
| Other comprehensive income (loss) before reclassifications and income taxes | (0.2) | (2.4) | (2.6) | 0.1 | 9.5 | 9.6 |
| Reclassification adjustments recognized in non-operating income |  |  |  |  | 0.6 | 0.6 |
|  | (0.2) | (2.4) | (2.6) | 0.1 | 10.1 | 10.2 |
| Net deferred tax benefits (income taxes) | 0.1 | 0.6 | 0.7 | 1.8 | (2.3) | (0.5) |
| Other comprehensive income (loss) | (0.1) | (1.8) | (1.9) | 1.9 | 7.8 | 9.7 |
| Balances at end of period | $(52.6) | $6.1 | $(46.5) | $(49.6) | $10.1 | $(39.5) |

---

The other comprehensive income (loss) in the table above excludes other comprehensive losses of $2.8 million and net gains of $7.4 million for the three months ended September 30, 2025 and 2024, respectively, related to redeemable non-controlling interests held in our consolidated products.

The changes in each component of accumulated other comprehensive income (loss), including reclassification adjustments for the nine months ended September 30, 2025 and 2024, are presented in the table below.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** |
| (in millions) | **Equity method investments** | **Consolidated investment products - variable interest entities** | **Total currency translation adjustments** | **Equity method investments** | **Consolidated investment products - variable interest entities** | **Total currency translation adjustments** |
| Balances at beginning of period | $(49.5) | $(2.2) | $(51.7) | $(51.9) | $4.4 | $(47.5) |
| Other comprehensive income (loss) before reclassifications and income taxes | (3.7) | 14.0 | 10.3 | 0.6 | 6.9 | 7.5 |
| Reclassification adjustments recognized in non-operating income |  | (3.1) | (3.1) |  | 0.6 | 0.6 |
|  | (3.7) | 10.9 | 7.2 | 0.6 | 7.5 | 8.1 |
| Net deferred tax benefits (income taxes) | 0.6 | (2.6) | (2.0) | 1.7 | (1.8) | (0.1) |
| Other comprehensive income (loss) | (3.1) | 8.3 | 5.2 | 2.3 | 5.7 | 8.0 |
| Balances at end of period | $(52.6) | $6.1 | $(46.5) | $(49.6) | $10.1 | $(39.5) |

---

The other comprehensive income (loss) in the table above excludes net gains of $8.2 million and $6.2 million for the nine months ended September 30, 2025 and 2024, respectively, related to redeemable non-controlling interests held in our consolidated products.

------

**NOTE 10 – SEGMENT REPORTING.**

We have one reportable segment: investment management services. We derive our revenue and net income globally and manage business activities on a consolidated basis.

We derive our revenues and net income from investment advisory services provided to individual and institutional investors. We also provide certain ancillary administrative services, including mutual fund transfer agent, fund and portfolio accounting, distribution, and shareholder services; participant recordkeeping and transfer agent services for defined contribution retirement plans; and other advisory services. Our revenues and net income depend largely on the total value and composition of our assets under management, as such, the consideration for our services is generally variable and recognized over time.

Our chief operating decision maker (CODM) is the chief executive officer. The CODM utilizes consolidated net income attributable to T. Rowe Price as reported on the consolidated income statement and certain non-GAAP metrics to assess performance and allocate resources. Based on these metrics, the CODM decides either to reinvest profits into the business based on our strategic priorities and/or return cash to stockholders through dividends and share repurchases.

We determined there are no significant segment expenses that require a separate disclosure, as the major categories of expenses regularly reviewed by the CODM to manage operations are disclosed in the consolidated statements of income. Quarterly reviews of expenses highlight those influenced by financial markets, such as distribution and servicing costs, as well as those that are both qualitatively and quantitatively significant. The measure of segment assets is reported on the balance sheet as total consolidated assets.

**NOTE 11 – COMMITMENTS AND CONTINGENCIES.**

**<u>COMMITMENTS.</u>**

T. Rowe Price Group, Inc. has committed $229 million for investment in future OHA product launches through 2026.

**<u>CONTINGENCIES.</u>**

**<u>Contingent Consideration</u>**

As part of the purchase consideration for our acquisition of OHA in December 2021, there is contingent

consideration in the amount of up to $900 million, payable in cash, that may be due as part of an earnout payment in 2026 and 2027 upon satisfying or exceeding certain defined revenue targets. These defined revenue targets will be evaluated on a cumulative basis from 2022 through 2026. About 22% of the earnout is conditioned upon continued service with T. Rowe Price Group, Inc. and was excluded from the purchase consideration and deemed compensatory. The fair value of the earnout is remeasured each reporting period and was valued at zero as of September 30, 2025 and December 31, 2024.

**<u>Other</u>**

Various claims against us arise in the ordinary course of business, including employment-related claims. In the opinion of management, after consultation with counsel, the likelihood of an adverse determination in one or more of these pending ordinary course of business claims that would have a material adverse effect on our financial position or results of operations is remote.

**NOTE 12 – RESTRUCTURING CHARGE.**

As separately disclosed in the unaudited consolidated income statement, we recognized a restructuring charge of $28.5 million in the third quarter of 2025, primarily related to severance. The remaining liability at September 30, 2025 of $10.1 million is reported in accrued compensation and related costs. This charge relates to our broad and ongoing plan to reduce expense growth and realign resources. This ongoing effort is designed to support investment in both existing and future capabilities.

------

**NOTE 13 – SUBSEQUENT EVENTS.**

In October 2025, the Board of Directors approved a plan to exit two owned office buildings in Owings Mills, Maryland. This decision is expected to result in a non-cash charge of up to $100 million in the fourth quarter of 2025, primarily reflecting the carrying value of the buildings, and will be recorded in the restructuring charge line of the consolidated income statement. This decision was made in connection with our broad and ongoing plan to reduce expense growth and realign resources to invest in existing and future capabilities.

------

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and the Board of Directors

T. Rowe Price Group, Inc.:

*Results of Review of Interim Financial Information* 

We have reviewed the consolidated balance sheet of T. Rowe Price Group, Inc. and subsidiaries (the Company) as of September 30, 2025, the related consolidated statements of income, comprehensive income, and stockholders' equity for the three-month and nine-month periods ended September 30, 2025 and 2024, the related consolidated statements of cash flows for the nine-month periods ended September 30, 2025 and 2024, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the interim financial information for it to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December 31, 2024, and the related consolidated statements of income, comprehensive income, stockholders' equity, and cash flows for the year then ended (not presented herein); and in our report dated February 14, 2025, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet as of December 31, 2024 is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

*Basis for Review Results*

This consolidated interim financial information is the responsibility of the Company's management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

/s/ KPMG LLP

Baltimore, Maryland

October 31, 2025

------

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.** 

***<u>OVERVIEW.</u>***

Our revenues and net income are derived primarily from investment advisory services provided globally to individual and institutional investors in a broad range of investment solutions across equity, fixed income, multi-asset, and alternatives capabilities. We also provide certain investment advisory clients with related administrative services, including distribution, mutual fund transfer agent, accounting, and shareholder services; participant recordkeeping and transfer agent services for defined contribution retirement plans; brokerage; trust services; and non-discretionary advisory services.

Investment advisory fees depend largely on the total value and composition of our assets under management. Accordingly, fluctuations in financial markets and in the composition of assets under management affect our revenues and results of operations.

We incur significant expenditures to develop new products and services and improve and expand our capabilities and distribution channels in order to attract new clients and additional investments from our existing clients. These efforts often involve costs that precede any future revenues we may recognize from an increase to our assets under management.

The investment management industry is evolving, facing challenging trends such as passive strategies taking market share from traditional active strategies; continued downward fee pressure; demand for new investment vehicles to meet client needs; and an ever-changing regulatory landscape. In this regard, we have ample liquidity and resources that allow us to take advantage of attractive growth opportunities. Furthermore, we have developed a broad and ongoing plan to align our expense growth with anticipated revenue growth. As a result, we have initiated certain actions to reduce expense growth, realign resources, and invest in existing and future capabilities, while also helping to offset ongoing inflationary pressures on compensation and contractual spending. These investments include hiring investment and distribution professionals, adopting new technologies, and offering new products to provide our clients with strong investment management expertise and services.

***<u>MARKET TRENDS.</u>***

Major stock indexes rose in the third quarter of 2025. Initially, equities were supported by generally favorable economic data and second-quarter corporate earnings reports, as well as some positive tariff-related news in the form of U.S. trade agreements with other nations. In August, however, a weaker-than-expected nonfarm payroll employment report for July—which included significant downward revisions to employment data for May and June—raised fears of an economic slowdown. Nevertheless, equities were buoyed by growing hopes that the Federal Reserve would resume reducing short-term interest rates; the last rate cut was in December 2024. Indeed, Fed officials decided in mid-September to reduce the fed funds target rate by 25 basis points and indicated there could be two additional rate cuts by the end of the year.

Developed non-U.S. equity markets also produced gains. Markets in several eurozone countries advanced more than 8% in U.S. dollar terms, while UK shares rose about 6%. Developed Asian markets were mostly positive in dollar terms, led by Hong Kong, Singapore, and Japan.

Stocks in emerging markets outperformed equities in developed non-U.S. markets. In emerging Asia, Chinese stocks climbed more than 20%, helped by cash-rich households seeking higher returns. In Latin America, most markets produced positive returns in dollar terms. In the emerging Europe, Middle East, and Africa (EMEA) region, markets were broadly positive. South African shares surged more than 20%, helped by rising metals prices and mining industry strength.

------

Returns of several major equity market indexes were as follows:

---

| | | |
|:---|:---|:---|
|<br>**Index** | **Three months ended**<br>**9/30/2025** | **Nine months ended**<br>**9/30/2025** |
| S&P 500 Index | 8.1% | 14.8% |
| NASDAQ Composite Index<sup>(1)</sup> | 11.2% | 17.3% |
| Russell 2000 Index | 12.4% | 10.4% |
| MSCI EAFE (Europe, Australasia, and Far East) Index | 4.8% | 25.7% |
| MSCI Emerging Markets Index | 11.0% | 28.2% |

---

<sup>(1)</sup> *Returns exclude dividends*

Global bond returns were mostly positive in the third quarter of 2025. In the U.S., Treasury bill yields declined in anticipation of a Federal Reserve interest rate cut in mid-September. On September 17, the central bank reduced the federal funds target rate from the 4.25% to 4.50% range to the 4.00% to 4.25% range. Intermediate- and long-term U.S. Treasury yields fell to a lesser extent. The 10-year U.S. Treasury note yield decreased from 4.24% to 4.16%.

In the investment-grade bond universe, sector performance was broadly positive. Corporate bonds and mortgage-backed securities performed best, while non-agency commercial mortgage-backed securities, asset-backed securities, and Treasuries lagged. Tax-free municipal bonds and high yield corporate bonds outperformed the taxable investment-grade bond market.

Bonds in developed non-U.S. markets produced slight negative returns in U.S. dollar terms. In the eurozone, longer-term bond yields rose in many countries, while the European Central Bank (ECB) kept key interest rates steady. In the UK, longer-term bond yields also increased, but the Bank of England reduced its key interest rate in August. The euro was little changed versus the greenback, but the British pound fell close to 2% versus the dollar. In Japan, long-term government bond yields increased, but the Bank of Japan kept the benchmark interest rate at 0.50%. The yen fell more than 2% versus the dollar. Emerging markets bonds produced positive returns in U.S. dollar terms. Dollar-denominated bonds outperformed bonds denominated in local currencies, as developing markets currencies were mixed versus the U.S. dollar.

Returns of several major bond market indexes were as follows:

---

| | | |
|:---|:---|:---|
|<br>**Index** | **Three months ended**<br>**9/30/2025** | **Nine months ended**<br>**9/30/2025** |
| Bloomberg U.S. Aggregate Bond Index | 2.0% | 6.1% |
| JPMorgan Global High Yield Index&nbsp;&nbsp;&nbsp;&nbsp; | 2.5% | 6.9% |
| Bloomberg Municipal Bond Index | 3.0% | 2.6% |
| Bloomberg Global Aggregate Ex-U.S. Dollar Bond Index | (0.6)% | 9.4% |
| JPMorgan Emerging Markets Bond Index Plus | 3.2% | 9.6% |
| ICE Bank of America U.S. High Yield Index | 2.4% | 7.1% |
| S&P UBS Leveraged Loan Index | 1.7% | 4.7% |

---

------

***<u>ASSETS UNDER MANAGEMENT.</u>***<sup>(1)</sup>

Assets under management ended the third quarter of 2025 at $1,767.2 billion, an increase of $90.4 billion from June 30, 2025. The increase was primarily driven by market appreciation and income, net of distributions not reinvested, of $89.1 billion, offset by net cash outflows of $7.9 billion. Beginning on July 1, 2025, assets under management include managed account - model delivery portfolios assets, which had $9.2 billion in assets as of that date, and are reflected in the increase from June 30, 2025 and December 31, 2024.

For the nine months ended September 30, 2025, the increase in assets under management was primarily driven by market appreciation, net of distributions not reinvested, of $182.8 billion, offset by net cash outflows of $31.4 billion.

The following tables detail changes in our assets under management, by asset class, during the three- and nine-month periods ended September 30, 2025:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** |
| (in billions) | **Equity** | **Fixed income, including money market** | **Multi-asset**<sup>(2)</sup> | **Alternatives**<sup>(3)</sup> | **Total** | **Equity** | **Fixed income, including money market** | **Multi-asset**<sup>(2)</sup> | **Alternatives**<sup>(3)</sup> | **Total** |
| Assets under management at beginning of period | $838.5 | $200.3 | $583.3 | $54.7 | $1676.8 | $829.7 | $188.1 | $536.0 | $52.8 | $1606.6 |
| Managed account - model delivery assets<sup>(4)</sup> | 9.2 |  |  |  | 9.2 | 9.2 |  |  |  | 9.2 |
| Net cash flows prior to manager-driven distributions | (14.4) | 4.4 | 1.3 | 1.6 | (7.1) | (51.7) | 11.0 | 7.7 | 3.8 | (29.2) |
| Manager-driven distributions |  |  |  | (0.8) | (0.8) |  |  |  | (2.2) | (2.2) |
| Net cash flows | (14.4) | 4.4 | 1.3 | 0.8 | (7.9) | (51.7) | 11.0 | 7.7 | 1.6 | (31.4) |
| Net market appreciation (depreciation) and income<sup>(5)</sup> | 52.1 | 3.4 | 33.1 | 0.5 | 89.1 | 98.2 | 9.0 | 74.0 | 1.6 | 182.8 |
| Change during the period | 46.9 | 7.8 | 34.4 | 1.3 | 90.4 | 55.7 | 20.0 | 81.7 | 3.2 | 160.6 |
| Assets under management at September 30, 2025 | $885.4 | $208.1 | $617.7 | $56.0 | $1767.2 | $885.4 | $208.1 | $617.7 | $56.0 | $1767.2 |

---

<sup>(1)</sup> *Includes assets in which T. Rowe Price and its affiliates have full discretionary authority along with managed account - model delivery assets.*

<sup>(2)</sup> *&nbsp;&nbsp;&nbsp;&nbsp;The underlying assets under management of the multi-asset portfolios have been aggregated and presented in this category and not reported in the equity and fixed income columns.*

<sup>(3)</sup> *The alternatives asset class includes strategies authorized to invest more than 50% of its holdings in private credit, leveraged loans, mezzanine, real assets/CRE, structured products, stressed / distressed, non-investment grade CLOs, special situations, or have absolute return as its investment objective. Generally, only those strategies with longer than daily liquidity are included. Unfunded capital commitments were $22.0 billion at September 30, 2025, $18.6 billion at June 30, 2025, and $16.2 billion at December 31, 2024, and are not reflected in fee basis AUM above.*

<sup>(4)</sup> *Amount represents the net assets as of July 1, 2025 and all activity for the quarter is reflected in the lines that follow.*

<sup>(5)</sup> *Includes net distributions not reinvested for the three- and nine-month periods ended September 30, 2025 of $0.4 billion and $1.3 billion, respectively.* 

Investment advisory clients outside the United States account for 8.7% of our assets under management at September 30, 2025 and June 30, 2025 and 8.8% at December 31, 2024.

Assets under management in our target date retirement portfolios, which are included in the multi-asset totals shown above, were $552.9 billion at September 30, 2025, $520.3 billion at June 30, 2025, and $475.6 billion at December 31, 2024. Net flows into these portfolios were $2.6 billion and $10.6 billion in the three- and nine-month periods ended September 30, 2025, respectively.

The firm's multi-asset investment division provides advisory solutions that include investment insights, strategic asset allocation design, tactical asset allocation recommendations, and portfolio rebalancing services. The assets in these solutions, predominantly in the United States, were $25.2 billion at September 30, 2025, compared with $24.1 billion at June 30, 2025.

------

We provide participant accounting and plan administration for retirement plans that primarily invest in the firm's U.S. mutual funds, collective investment trusts and products outside of the firm's complex. As of September 30, 2025, our assets under administration were $315 billion, of which $178 billion are assets we manage.

***<u>INVESTMENT PERFORMANCE.</u>***<sup>(1)</sup>

*S*trong investment performance and brand awareness is a key driver to attracting and retaining assets—and to our long-term success. Our performance disclosures include specific asset classes, assets under management weighted performance, U.S. fund performance against passive peers, and composite performance against benchmarks. The following tables present investment performance for the one-, three-, five-, and 10-years ended September 30, 2025. Past performance is not a guarantee nor a reliable indicator of future performance.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **% of U.S. funds that outperformed Morningstar median**<sup>(2),(3)</sup>  | **% of U.S. funds that outperformed Morningstar median**<sup>(2),(3)</sup>  | **% of U.S. funds that outperformed Morningstar median**<sup>(2),(3)</sup>  | **% of U.S. funds that outperformed Morningstar median**<sup>(2),(3)</sup>  | **% of U.S. funds that outperformed Morningstar median**<sup>(2),(3)</sup>  |
|  | 1 year | 3 years | 5 years | 10 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | 39% | 41% | 50% | 56% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed Income | 61% | 67% | 55% | 59% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-Asset | 45% | 57% | 44% | 65% |
| &nbsp;&nbsp;&nbsp;&nbsp;All Funds | 48% | 54% | 50% | 60% |
| **% of U.S. funds that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds that outperformed passive peer median**<sup>(2),(4)</sup> |
|  | 1 year | 3 years | 5 years | 10 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | 27% | 43% | 41% | 44% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed Income | 59% | 58% | 58% | 59% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-Asset | 27% | 36% | 47% | 48% |
| &nbsp;&nbsp;&nbsp;&nbsp;All Funds | 35% | 44% | 48% | 49% |
| **% of composites that outperformed benchmarks**<sup>(5)</sup> | **% of composites that outperformed benchmarks**<sup>(5)</sup> | **% of composites that outperformed benchmarks**<sup>(5)</sup> | **% of composites that outperformed benchmarks**<sup>(5)</sup> | **% of composites that outperformed benchmarks**<sup>(5)</sup> |
|  | 1 year | 3 years | 5 years | 10 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | 19% | 24% | 29% | 51% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed Income | 66% | 52% | 62% | 79% |
| &nbsp;&nbsp;&nbsp;&nbsp;All Composites | 40% | 36% | 43% | 61% |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>AUM Weighted Performance</u>** | | | | |
| **% of U.S. funds AUM that outperformed Morningstar median**<sup>(2),(3)</sup> | **% of U.S. funds AUM that outperformed Morningstar median**<sup>(2),(3)</sup> | **% of U.S. funds AUM that outperformed Morningstar median**<sup>(2),(3)</sup> | **% of U.S. funds AUM that outperformed Morningstar median**<sup>(2),(3)</sup> | **% of U.S. funds AUM that outperformed Morningstar median**<sup>(2),(3)</sup> |
|  | 1 year | 3 years | 5 years | 10 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | 54% | 58% | 53% | 73% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed Income | 80% | 76% | 74% | 79% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-Asset | 43% | 78% | 67% | 93% |
| &nbsp;&nbsp;&nbsp;&nbsp;All Funds | 53% | 64% | 57% | 78% |
| **% of U.S. funds AUM that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds AUM that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds AUM that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds AUM that outperformed passive peer median**<sup>(2),(4)</sup> | **% of U.S. funds AUM that outperformed passive peer median**<sup>(2),(4)</sup> |
|  | 1 year | 3 years | 5 years | 10 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | 9% | 50% | 21% | 45% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed Income | 73% | 69% | 82% | 69% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-Asset | 15% | 55% | 68% | 94% |
| &nbsp;&nbsp;&nbsp;&nbsp;All Funds | 14% | 52% | 36% | 58% |
| **% of composites AUM that outperformed benchmarks**<sup>(5)</sup> | **% of composites AUM that outperformed benchmarks**<sup>(5)</sup> | **% of composites AUM that outperformed benchmarks**<sup>(5)</sup> | **% of composites AUM that outperformed benchmarks**<sup>(5)</sup> | **% of composites AUM that outperformed benchmarks**<sup>(5)</sup> |
|  | 1 year | 3 years | 5 years | 10 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | 14% | 29% | 27% | 38% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed Income | 74% | 50% | 69% | 72% |
| &nbsp;&nbsp;&nbsp;&nbsp;All Composites | 25% | 33% | 34% | 43% |

---

As of September 30, 2025, 63 of 142 (44.4%) of the firm's rated U.S. mutual funds (across primary share classes) received an overall rating of 4 or 5 stars. By comparison, 32.5% of Morningstar's fund population is given a rating of 4 or 5 stars<sup>(6)</sup>. In addition, 59%<sup>(6)</sup> of AUM in the firm's rated U.S. mutual funds (across primary share classes) ended September 30, 2025 with an overall rating of 4 or 5 stars.

<sup>(1)</sup> *The investment performance reflects that of T. Rowe Price U.S. mutual funds, ETFs, and composites.*

<sup>(2)</sup> *Source:© 2025 Morningstar, Inc. All rights reserved. The information contained herein: 1) is proprietary to Morningstar and/or its content providers; 2) may not be copied or distributed; and 3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.* 

<sup>(3)</sup> *Source: Morningstar. Primary share class only. Excludes money market mutual funds, funds with an operating history of less than one year, T. Rowe Price passive funds, and T. Rowe Price funds that are clones of other funds. The top chart reflects the percentage of T. Rowe Price funds with 1 year, 3 year, 5 year, and 10 year track record that outperformed the Morningstar category median. The bottom chart reflects the percentage of T. Rowe Price funds AUM that has outperformed for the time periods indicated. Total AUM included for this analysis includes $337B for 1 year, $328B for 3 years, $326B for 5 years, and $325B for 10 years.* 

<sup>(5)</sup> *Composite net returns are calculated using the highest applicable separate account fee schedule. Excludes money market composites. All composites compared to official GIPS composite primary benchmark. The top chart reflects the percentage of T. Rowe Price composites with 1 year, 3 year, 5 year, and 10 year track record that are outperforming their benchmarks. The bottom chart reflects the percentage of T. Rowe Price composite AUM that has outperformed for the time periods indicated. Total AUM included for this analysis includes $1,567B for 1 year, $1,559B for 3 years, $1,554B for 5 years, and $1,518B for 10 years.* 

<sup>(6)</sup> *The Morningstar Rating™ for funds is calculated for funds with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. Morningstar gives its best ratings of 5 or 4 stars to the top 32.5% of all funds (of the 32.5%,10% get 5 stars and 22.5% get 4 stars). The Overall Morningstar Rating™ is derived from a weighted average of the performance figures associated with a fund's 3, 5, and 10 year (if applicable) Morningstar Rating™ metrics.*

------

***<u>RESULTS OF OPERATIONS.</u>***

The following table and discussion sets forth information regarding our consolidated financial results for the three- and nine-month periods ended September 30, 2025 and 2024 on a U.S. GAAP and a non-GAAP basis. The non-GAAP basis adjusts for the impact of our consolidated investment products, the impact of market movements on the deferred compensation liabilities and related economic hedges, investment income related to certain other investments, acquisition-related amortization and costs, impairment charges, and certain nonrecurring charges and gains, if any.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Q3 2025 vs. Q3 2024** | **Q3 2025 vs. Q3 2024** | **Nine months ended** | **Nine months ended** | **YTD 2025 vs. YTD 2024** | **YTD 2025 vs. YTD 2024** |
| (in millions, except per-share data) | **9/30/2025** | **9/30/2024** | **$ change** | **% change**<sup>(1)</sup> | **9/30/2025** | **9/30/2024** | **$ change** | **% change**<sup>(1)</sup> |
| **<u>U.S. GAAP basis</u>** |  |  |  |  |  |  |  |  |
| Investment advisory fees<sup>(2)</sup> | $1698.7 | $1627.3 | $71.4 | 4.4% | $4864.7 | $4732.5 | $132.2 | 2.8% |
| Performance-based advisory fees<sup>(2)</sup> | $6.4 | $5.6 | $0.8 | 14.3% | $23.2 | $40 | $(16.8) | (42.0)% |
| Capital allocation-based income<sup>(3)</sup> | $42 | $4.6 | $37.4 | n/m | $40.4 | $51.8 | $(11.4) | n/m |
| Net revenues | $1893.5 | $1785.6 | $107.9 | 6.0% | $5380.7 | $5269.1 | $111.6 | 2.1% |
| Operating expenses | $1250.3 | $1172 | $78.3 | 6.7% | $3662.9 | $3504.2 | $158.7 | 4.5% |
| Net operating income | $643.2 | $613.6 | $29.6 | 4.8% | $1717.8 | $1764.9 | $(47.1) | (2.7)% |
| Non-operating income (loss) | $238.4 | $212.5 | $25.9 | 12.2% | $544.6 | $481.7 | $62.9 | 13.1% |
| Net income to T. Rowe Price Group, Inc. | $646.1 | $603 | $43.1 | 7.1% | $1641.8 | $1660.2 | $(18.4) | (1.1)% |
| Diluted earnings per common share | $2.87 | $2.64 | $0.23 | 8.7% | $7.25 | $7.23 | $0.02 | 0.3% |
| Weighted average common shares outstanding assuming dilution | 219.7 | 222.8 | (3.1) | (1.4)% | 220.9 | 223.5 | (2.6) | (1.2)% |
| **<u>Adjusted basis</u>**<sup>(4)</sup> |  |  |  |  |  |  |  |  |
| Operating expenses | $1134.4 | $1099 | $35.4 | 3.2% | $3416.7 | $3276.2 | $140.5 | 4.3% |
| Operating expenses, excluding accrued carried interest related compensation | $1111.8 | $1087.4 | $24.4 | 2.2% | $3376.9 | $3237.6 | $139.3 | 4.3% |
| Net operating income | $774.1 | $718.4 | $55.7 | 7.8% | $2029.1 | $2065.7 | $(36.6) | (1.8)% |
| Non-operating income (loss) | $50.2 | $51.2 | $(1.0) | (2.0)% | $132.8 | $114.4 | $18.4 | 16.1% |
| Net income to T. Rowe Price Group, Inc. | $631.7 | $586.5 | $45.2 | 7.7% | $1647.8 | $1654.7 | $(6.9) | (0.4)% |
| Diluted earnings per common share | $2.81 | $2.57 | $0.24 | 9.3% | $7.28 | $7.21 | $0.07 | 1.0% |
| **<u>Assets under management (AUM) (in billions)</u>** | **<u>Assets under management (AUM) (in billions)</u>** | **<u>Assets under management (AUM) (in billions)</u>** |  |  |  |  |  |  |
| Average AUM | $1723 | $1589.5 | $133.5 | 8.4% | $1644.4 | $1536.2 | $108.2 | 7.0% |
| Ending AUM | $1767.2 | $1630.9 | $136.3 | 8.4% | $1767.2 | $1630.9 | $136.3 | 8.4% |
| **<u>Investment advisory annualized effective fee rate (EFR) (in bps)</u>** | **<u>Investment advisory annualized effective fee rate (EFR) (in bps)</u>** | **<u>Investment advisory annualized effective fee rate (EFR) (in bps)</u>** | **<u>Investment advisory annualized effective fee rate (EFR) (in bps)</u>** | **<u>Investment advisory annualized effective fee rate (EFR) (in bps)</u>** |  |  |  |  |
| EFR without performance-based fees | 39.1 | 40.7 | (1.6) | (3.9)% | 39.6 | 41.2 | (1.6) | (3.9)% |
| EFR with performance-based fees | 39.3 | 40.9 | (1.6) | (3.9)% | 39.7 | 41.5 | (1.8) | (4.3)% |

---

<sup>(1)</sup> *n/m - the percentage change is not meaningful.*

<sup>(2)</sup> *2024 performance-based advisory fees are reported separately from investment advisory fees to align with the presentation in 2025.*

<sup>(3)</sup> *Capital allocation-based income represents the change in accrued carried interest.* 

<sup>(4)</sup> *See the reconciliation to the comparable U.S. GAAP measures at the end of the Results of Operations section of this Management's Discussion and Analysis.* 

**<u>Results Overview - Quarter ended September 30, 2025</u>**

*<u>Net revenues</u>* consist of investment advisory revenues; performance-based advisory fees; administrative, distribution, services, and other fees; and capital allocation-based income. About 90% of our net revenues are related to investment advisory fees. Total net revenues were $1,893.5 million in the third quarter of 2025, a 6.0%

------

increase compared to $1,785.6 million in the 2024 quarter. The increase was driven primarily by higher investment advisory fees on higher average assets under management and capital allocation-based income.

Investment advisory fees are generally earned based on the value and composition of our assets under management, which change based on fluctuations in financial markets and net cash flows. As our average assets under management increase or decrease in a given period, the level of our investment advisory fee revenue for that same period generally fluctuates in a similar manner. Our annualized effective fee rates can be impacted by market or cash flow related shifts among asset classes and products, including those with tiered-fee structures, along with price changes we make in existing products.

Capital allocation-based income will fluctuate quarter-to-quarter to reflect the adjustment to accrued carried interest for the change in value of certain affiliated funds assuming the funds' underlying investments were realized as of the end of the period.

*<u>Operating expenses</u>* on a U.S. GAAP basis were $1,250.3 million in the third quarter of 2025, a 6.7% increase over the comparable 2024 period. On a non-GAAP basis, operating expenses were $1,134.4 million, a 3.2% increase over the comparable 2024 period.

Compared to the third quarter of 2024, the increase in U.S. GAAP operating expenses was driven by a few items, including the restructuring charge, primarily compensation and related, associated with our ongoing plan to reduce expense growth and realign resources to invest in existing and future capabilities. Additionally, higher technology and facilities costs and accrued carried interest compensation contributed to the rise in U.S. GAAP operating expenses and were the main drivers of the increase in non-GAAP operating expenses over the 2024 period. Given the non-recurring nature of the restructuring charge, we have excluded this charge from our non-GAAP operating expenses measures.

*<u>Operating margin</u>* in the third quarter of 2025 was 34.0% on a U.S. GAAP basis, compared to 34.4% in the third quarter of 2024. The restructuring charge was the primary driver of the decrease in the operating margin.

*<u>Diluted earnings per share</u>* was $2.87 for the third quarter of 2025 compared to $2.64 for the third quarter of 2024. The increase was primarily driven by higher operating income, higher investment gains, and fewer weighted average shares outstanding compared to the 2024 period.

On a non-GAAP basis, diluted earnings per share was $2.81 for the third quarter of 2025 as compared to $2.57 for the third quarter of 2024. The increase was primarily due to higher adjusted operating income and fewer weighted average shares outstanding compared to the 2024 period.

**<u>Results Overview - Year-to-Date ended September 30, 2025</u>**

*<u>Net revenues</u>* consist of investment advisory revenues; performance-based advisory fees; administrative, distribution, services, and other fees; and capital allocation-based income. More than 90% of our net revenues for the nine months ended September 30, 2025 are related to investment advisory fees. Total net revenues were $5,380.7 million in the nine months ended September 30, 2025, a 2.1% increase over $5,269.1 million in the 2024 period. The increase was primarily driven by a 2.8% increase in investment advisory fee revenue as average assets under management increased by 7.0% and a $7.6 million increase in non-advisory revenues, partially offset by a $16.8 million decrease in performance-based advisory fees and a $11.4 million decrease in capital allocation-based income (change in accrued carried interest) earned from investments in certain affiliated funds.

*<u>Operating expenses</u>* on a U.S. GAAP basis were $3,662.9 million in the nine months ended September 30, 2025, compared with $3,504.2 million over the comparable 2024 period. On a non-GAAP basis, operating expenses were $3,416.7 million, a 4.3% increase over the comparable 2024 period.

Compared to the nine months ended September 30, 2024, the increase in U.S. GAAP operating expenses were primarily due to compensation and related costs, the restructuring charge, technology and facility costs, and distribution and servicing costs. The drivers of the increase in non-GAAP operating expenses were the same as U.S. GAAP with the exception of the restructuring charge, which is excluded from our non-GAAP operating expenses measures.

------

*<u>Operating margin</u>* in the nine months ended September 30, 2025 was 31.9% on a U.S. GAAP basis, compared to 33.5% earned in the 2024 period. The decrease was primarily driven by operating expense growth outpacing net revenue growth.

*<u>Diluted earnings per share</u>* was $7.25 for the nine months ended September 30, 2025, compared to $7.23 for 2024 period. On a non-GAAP basis, adjusted diluted earnings per share was $7.28 for the nine months ended September 30, 2025, compared to $7.21 for the 2024 period. The increase was primarily due to fewer weighted average shares outstanding and higher investment gains, which were partially offset by lower operating income.

**<u>Net revenues</u>**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Q3 2025 vs. Q3 2024** | **Q3 2025 vs. Q3 2024** | **Nine months ended** | **Nine months ended** | **YTD 2025 vs. YTD 2024** | **YTD 2025 vs. YTD 2024** |
| (in millions) | **9/30/2025** | **9/30/2024** | **$ change** | **% change**<sup>(1)</sup> | **9/30/2025** | **9/30/2024** | **$ change** | **% change**<sup>(1)</sup> |
| **Investment advisory fees**<sup>(2)</sup> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity | $1011.8 | $978.5 | $33.3 | 3.4% | $2894.6 | $2858.5 | $36.1 | 1.3% |
| &nbsp;&nbsp;&nbsp;Fixed income, including money market | 110.1 | 104.1 | 6.0 | 5.8% | 319.2 | 304.5 | 14.7 | 4.8% |
| &nbsp;&nbsp;&nbsp;Multi-asset | 492.1 | 465.8 | 26.3 | 5.6% | 1402.7 | 1340.3 | 62.4 | 4.7% |
| &nbsp;&nbsp;&nbsp;Alternatives | 84.7 | 78.9 | 5.8 | 7.4% | 248.2 | 229.2 | 19.0 | 8.3% |
|  | 1698.7 | 1627.3 | 71.4 | 4.4% | 4864.7 | 4732.5 | 132.2 | 2.8% |
| **Performance-based advisory fees**<sup>(2)</sup> | 6.4 | 5.6 | 0.8 | 14.3% | 23.2 | 40.0 | (16.8) | (42.0)% |
| **Capital allocation-based income** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Change in accrued carried interest | 56.2 | 35.1 | 21.1 | 60.1% | 101.9 | 121.6 | (19.7) | (16.2)% |
| &nbsp;&nbsp;Acquisition-related amortization and impairments | (14.2) | (30.5) | 16.3 | (53.4)% | (61.5) | (69.8) | 8.3 | (11.9)% |
|  | 42.0 | 4.6 | 37.4 | n/m | 40.4 | 51.8 | (11.4) | n/m |
| **Administrative, distribution, services, and other fees** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Administrative fees | 124.1 | 125.4 | (1.3) | (1.0)% | 387.5 | 378.4 | 9.1 | 2.4% |
| &nbsp;&nbsp;&nbsp;Distribution and servicing fees | 22.3 | 22.7 | (0.4) | (1.8)% | 64.9 | 66.4 | (1.5) | (2.3)% |
|  | 146.4 | 148.1 | (1.7) | (1.1)% | 452.4 | 444.8 | 7.6 | 1.7% |
| **Net revenues** | $1893.5 | $1785.6 | $107.9 | 6.0% | $5380.7 | $5269.1 | $111.6 | 2.1% |
| **Average AUM (in billions):** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity | $865.8 | $813.1 | $52.7 | 6.5% | $825.7 | $791.4 | $34.3 | 4.3% |
| &nbsp;&nbsp;&nbsp;Fixed income, including money market | 203.8 | 183.3 | 20.5 | 11.2% | 197.8 | 175.9 | 21.9 | 12.5% |
| &nbsp;&nbsp;&nbsp;Multi-asset | 597.7 | 542.3 | 55.4 | 10.2% | 566.8 | 519.9 | 46.9 | 9.0% |
| &nbsp;&nbsp;&nbsp;Alternatives | 55.7 | 50.8 | 4.9 | 9.6% | 54.1 | 49.0 | 5.1 | 10.4% |
| **Average AUM** | $1723.0 | $1589.5 | $133.5 | 8.4% | $1644.4 | $1536.2 | $108.2 | 7.0% |
| **Investment advisory annualized effective fee rate (EFR) (in bps)** | **Investment advisory annualized effective fee rate (EFR) (in bps)** | **Investment advisory annualized effective fee rate (EFR) (in bps)** | **Investment advisory annualized effective fee rate (EFR) (in bps)** | **Investment advisory annualized effective fee rate (EFR) (in bps)** |  |  |  |  |
| EFR without performance-based fees | 39.1 | 40.7 | (1.6) | (3.9)% | 39.6 | 41.2 | (1.6) | (3.9)% |
| EFR with performance-based fees | 39.3 | 40.9 | (1.6) | (3.9)% | 39.7 | 41.5 | (1.8) | (4.3)% |

---

<sup>(1)</sup> *n/m - the percentage change is not meaningful.*

<sup>(2)</sup> *2024 performance-based advisory fees are reported separately from investment advisory fees to align with the 2025 presentation.*

------

*<u>Investment advisory fees</u>* in the third quarter of 2025 increased 4.4% over the comparable 2024 quarter while average assets under management increased $133.5 billion, or 8.4%, to $1,723.0 billion. For the nine months ended September 30, 2025, investment advisory revenues increased 2.8% over the comparable 2024 period as average assets under management increased $108.2 billion, or 7.0%, to $1,644.4 billion.

The average annualized effective fee rate earned for the three- and nine-month periods ended September 30, 2025 declined from the comparable 2024 periods primarily due to client flows and transfers shifting assets under management toward lower-fee strategies and products.

*<u>Performance-based advisory fees</u>* in the third quarter of 2025 and 2024 were earned primarily from alternatives strategies, and from alternatives and equity strategies for the nine months ended September 30, 2025 and 2024.

*<u>Capital allocation-based income</u>* includes the change in accrued carried interest along with acquisition-related amortization and impairments. In the third quarter of 2025, the change in accrued carried interest increased net revenues by $56.2 million compared to $35.1 million in the 2024 period. For the nine months ended September 30, 2025, the change in accrued carried interest increased net revenues by $101.9 million compared to $121.6 million for the 2024 period. The difference in the change in accrued carried interest for the 2025 periods compared to the 2024 periods was due to relative market impacts and performance. The decrease in acquisition-related amortization and impairments for the 2025 periods from the comparable 2024 periods was primarily due to higher impairments recognized in prior periods.

A portion of the capital allocation-based income is passed through to certain associates as compensation and the related expense recognized in compensation and related costs with the unpaid amount reported as non-controlling interest on the unaudited consolidated balance sheets.

*<u>Administrative, distribution, services, and other fees</u>* in the third quarter of 2025 were $146.4 million, a decrease of $1.7 million, or 1.1%, from the comparable 2024 quarter. For the nine months ended September 30, 2025, these fees were $452.4 million, an increase of $7.6 million, or 1.7%, from the 2024 period. In the third quarter of 2025, we began reporting revenue from managed account model delivery assets and certain other advisory services in investment advisory fees, which was over $13 million in Q3 2025. This reclassification was the primary driver of the decline in administrative, distribution, services, and other fees, partially offset by higher transfer agents services compared to the 2024 period. For the nine months ended September 30, 2025, the increase was primarily due to higher recordkeeping fees and higher transfer agent services.

Our net revenues reflect the elimination of advisory and administrative fee revenue earned from our consolidated

investment products. The corresponding expenses recognized by these products, which are consolidated in our financial statements, were also eliminated from operating expenses. For the third quarter, we eliminated net revenue of $0.8 million in 2025 and $1.3 million in 2024. For the nine months ended September 30, we eliminated net revenue of $3.6 million in 2025 and $3.0 million in 2024.

------

**<u>Operating expenses</u>**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Q3 2025 vs. Q3 2024** | **Q3 2025 vs. Q3 2024** | **Nine months ended** | **Nine months ended** | **YTD 2025 vs. YTD 2024** | **YTD 2025 vs. YTD 2024** |
| (in millions) | **9/30/2025** | **9/30/2024** | **$ change** | **% change**<sup>(1)</sup> | **9/30/2025** | **9/30/2024** | **$ change** | **% change**<sup>(1)</sup> |
| Compensation, benefits and related costs | $632.5 | $632.9 | $(0.4) | (0.1)% | $1939.2 | $1898.0 | $41.2 | 2.2% |
| Acquisition-related retention agreements | 14.2 | 4.0 | 10.2 | n/m | 42.5 | 30.6 | 11.9 | 38.9% |
| Capital allocation-based income compensation<sup>(2)</sup> | 16.8 | (2.0) | 18.8 | n/m | 14.9 | 8.8 | 6.1 | 69.3% |
| Market-related change in deferred compensation liabilities | 50.8 | 43.4 | 7.4 | 17.1% | 109.9 | 111.0 | (1.1) | (1.0)% |
| Total compensation and related costs | 714.3 | 678.3 | 36.0 | 5.3% | 2106.5 | 2048.4 | 58.1 | 2.8% |
| Distribution and servicing | 95.8 | 91.6 | 4.2 | 4.6% | 281.9 | 261.2 | 20.7 | 7.9% |
| Advertising and promotion | 21.3 | 20.8 | 0.5 | 2.4% | 77.3 | 79.4 | (2.1) | (2.6)% |
| Product and recordkeeping related costs | 78.7 | 75.0 | 3.7 | 4.9% | 237.3 | 223.0 | 14.3 | 6.4% |
| Technology, occupancy, and facility costs | 183.2 | 164.0 | 19.2 | 11.7% | 530.2 | 474.8 | 55.4 | 11.7% |
| General, administrative, and other | 101.7 | 104.2 | (2.5) | (2.4)% | 314.5 | 305.5 | 9.0 | 2.9% |
| Change in fair value of contingent consideration |  | (13.4) | 13.4 | n/m |  | (13.4) | 13.4 | n/m |
| Acquisition-related amortization and impairment costs | 26.8 | 51.5 | (24.7) | (48.0)% | 86.7 | 125.3 | (38.6) | (30.8)% |
| Restructuring charge | 28.5 |  | 28.5 | n/m | 28.5 |  | 28.5 | n/m |
| &nbsp;&nbsp;&nbsp;Total operating expenses | $1250.3 | $1172.0 | $78.3 | 6.7% | $3662.9 | $3504.2 | $158.7 | 4.5% |
| Total adjusted operating expenses <sup>(3)</sup> | $1134.4 | $1099.0 | $35.4 | 3.2% | $3416.7 | $3276.2 | $140.5 | 4.3% |

---

<sup>(1)</sup> *n/m - The percentage change is not meaningful.*

<sup>(2)</sup> *Capital allocation-based income compensation represents the change in accrued carried interest compensation along with acquisition-related, non-cash amortization and impairments.*

<sup>(3)</sup> *See the reconciliation to the comparable U.S. GAAP measures at the end of the Results of Operations section of this Management's Discussion and Analysis.*

*<u>Compensation, benefits, and related costs</u>* were $632.5 million in the third quarter of 2025, a decrease of $0.4 million, or 0.1%, compared to the 2024 quarter. For the nine months ended September 30, 2025, these costs were $1,939.2 million, an increase of $41.2 million, or 2.2%, compared to the 2024 period.

For the third quarter of 2025, the decrease was due to lower temporary personnel, offset by higher salaries and related benefits and lower capitalized labor. For the nine months ended September 30, 2025, the increase was primarily due to higher salaries and related benefits, higher long-term incentive compensation, and lower capitalized labor. These increases were partially offset by lower temporary personnel and other employee related costs.

The firm employed 7,830 associates at September 30, 2025, a decrease of 2.9% from 8,063 associates at June 30, 2025, a decrease of 4.0% from the end of 2024, and a decrease of 3.4% from September 30, 2024. The decrease in associates over each period is primarily driven by the workforce action in July 2025.

*<u>Distribution and servicing costs</u>* were $95.8 million for the third quarter of 2025, an increase of $4.2 million, or 4.6%, from $91.6 million recognized in the 2024 quarter. For the nine months ended September 30, 2025, these costs were $281.9 million, an increase of $20.7 million, or 7.9%, from $261.2 million recognized in the comparable 2024 period. The increases in both periods were primarily driven by higher average assets under management distributed through intermediaries.

------

The costs in this expense category include amounts paid to third-party intermediaries that source the assets of certain share classes of our U.S. mutual funds, ETFs, and our international products, such as our Japanese ITMs and SICAVs. These costs are offset entirely by the distribution revenue we earn and report in net revenues: 12b-1 revenue is recognized in administrative, distribution, services, and other fees for the Advisor and R share classes of the U.S. mutual funds and investment advisory fee revenue for our international products and ETFs.

*<u>Product and recordkeeping related costs</u>* were $78.7 million in the third quarter of 2025, an increase of $3.7 million, or 4.9%, compared to $75.0 million in the 2024 quarter. For the nine months ended September 30, 2025, these costs were $237.3 million, an increase of $14.3 million, or 6.4%, from $223.0 million recognized in the comparable 2024 period. The increases in both periods were primarily due to higher recordkeeping fees and other product related costs. Also contributing to the nine month increase was higher custody fees related to our trust products.

*<u>Technology, occupancy, and facility costs</u>* were $183.2 million in the third quarter of 2025, an increase of $19.2 million, or 11.7%, compared to the $164.0 million recognized in the 2024 quarter. For the nine months ended September 30, 2025, these costs were $530.2 million, an increase of $55.4 million, or 11.7%, compared with the 2024 period. The increases in both periods were primarily due to higher technology costs, including hosted solutions and depreciation. Also contributing to the nine month increase was higher occupancy and facility costs related to our new corporate headquarters, which was occupied in March 2025, and a non-recurring cost benefit related to our UK facility in the first quarter of 2024.

*<u>General, administrative, and other expenses</u>* were $101.7 million in the third quarter of 2025, a decrease of $2.5 million, or 2.4%, compared to the $104.2 million recognized in the 2024 quarter. For the nine months ended September 30, 2025, these costs were $314.5 million, an increase of $9.0 million, or 2.9%, compared with the 2024 period. For the third quarter of 2025, the decrease was primarily related to a non-recurring cost recovery recognized during the quarter. For the nine months ended September 30, 2025, the increase was primarily driven by higher professional fees, information services, and other administrative costs. These increases were partially offset by the non-recurring cost recovery recognized in the third quarter of 2025 and lower external research fees.

*<u>Acquisition-related amortization and impairment costs</u>* primarily relate to the indefinite- and definite-lived intangible assets identified and separately recognized, at fair value, on acquisition date. For the third quarter of 2025, we recognized $26.8 million in amortization and impairments related to intangible assets, compared to $51.5 million in the 2024 quarter. For the nine months ended September 30, 2025, we recognized $86.7 million in amortization and impairments related to intangible assets, compared to $125.3 million, in the 2024 period. For the 2024 periods, intangible asset impairment charges totaled $25.6 million for the third quarter and $59.7 million for the year-to-date period. If conditions that led us to recognize impairment charges worsen, additional impairments may be recognized in future periods.

*<u>Restructuring charge</u>* of $28.5 million for three- and nine-month periods ended September 30, 2025 reflects compensation costs, primarily severance, incurred in connection with the July workforce action. This was related to our previously announced broad and ongoing plan to reduce expense growth and realign resources. This ongoing effort is designed to support investment in both existing and future capabilities.

------

**<u>Non-operating income (loss)</u>**

Non-operating income for the third quarter of 2025 was $238.4 million compared to $212.5 million in the 2024 quarter. The following table details the components of non-operating income for both the three- and nine-month periods ended September 30, 2025 and 2024.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Nine months ended** | **Nine months ended** |
| (in millions) | **9/30/2025** | **9/30/2024** | **9/30/2025** | **9/30/2024** |
| Net gains (losses) from non-consolidated investment products |  |  |  |  |
| Cash and discretionary investments |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend income | $38.1 | $37.4 | $102.3 | $98.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Market-related gains (losses) and equity in earnings (losses) | 12.1 | 5.9 | 29.6 | 6.2 |
| **Total cash and discretionary investments** | **50.2** | **43.3** | **131.9** | **105.0** |
| Seed capital investments |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend income | 0.5 | 0.5 | 0.9 | 0.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Market-related gains (losses) and equity in earnings (losses) | 17.1 | 21.3 | 42.6 | 60.1 |
| **Total seed capital investments** | **17.6** | **21.8** | **43.5** | **60.9** |
| **Total cash, discretionary, and seed investments** | **67.8** | **65.1** | **175.4** | **165.9** |
| Net gains (losses) recognized upon deconsolidation |  | (0.6) | 3.1 | (0.6) |
| Investments used to hedge the deferred compensation liabilities | 53.0 | 41.1 | 112.8 | 105.6 |
| **Total net gains (losses) from non-consolidated investment products** | **120.8** | **105.6** | **291.3** | **270.9** |
| Other investment income | 40.4 | 13.4 | 67.7 | 47.6 |
| **Net gains (losses) on investments** | **161.2** | **119.0** | **359.0** | **318.5** |
| Net gains (losses) on consolidated investment products | 72.6 | 85.9 | 183.1 | 166.7 |
| Other gains (losses), including foreign currency gains (losses) | 4.6 | 7.6 | 2.5 | (3.5) |
| **Non-operating income (loss)** | $**238.4** | $**212.5** | $**544.6** | $**481.7** |
| **Adjusted non-operating income (loss)**<sup>(1)</sup> | $**50.2** | $**51.2** | $**132.8** | $**114.4** |

---

<sup>(1)</sup> *See the reconciliation to the comparable U.S. GAAP measures at the end of the Results of Operations section of this Management's Discussion and Analysis.* 

Higher investment gains earned by our investment portfolio during the three- and nine-month periods ended September 30, 2025 compared to the 2024 periods were primarily due to higher cash and investment holdings coupled with stronger overall market returns.

The table above shows the net investment income of the underlying portfolios of the consolidated investment products, not just the income from our ownership share. The table below displays how consolidated investment products affected the individual lines of our unaudited consolidated income statements and the portion attributable to our interest.

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Nine months ended** | **Nine months ended** |
| (in millions) | **9/30/2025** | **9/30/2024** | **9/30/2025** | **9/30/2024** |
| Operating expenses reflected in net operating income | $(2.2) | $(2.4) | $(7.1) | $(7.3) |
| Net investment income (loss) reflected in non-operating income | 72.6 | 85.9 | 183.1 | 166.7 |
| Impact on income before taxes | $70.4 | $83.5 | $176.0 | $159.4 |
| Net income (loss) attributable to our interest in the consolidated investment products | $30.0 | $46.1 | $70.1 | $100.5 |
| Net income (loss) attributable to redeemable non-controlling interests (unrelated third-party investors) | 40.4 | 37.4 | 105.9 | 58.9 |
| Impact on income before taxes | $70.4 | $83.5 | $176.0 | $159.4 |

---

**<u>Provision for income taxes</u>**

The GAAP effective tax rate for the third quarter of 2025 was 22.1% compared with 22.5% in the third quarter of 2024. These quarterly rates were the result of an overall year-to-date rate of 22.8% for 2025 and 23.5% for 2024. The following table reconciles the statutory federal income tax rate to our effective tax rate on a U.S. GAAP basis for the nine months ended September 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Nine months ended** | **Nine months ended** |
| | **9/30/2025** | **9/30/2024** |
| Statutory U.S. federal income tax rate | 21.0% | 21.0% |
| State income taxes for current year, net of federal income tax benefits<sup>(1)</sup> | 2.5 | 2.7 |
| Net (income) losses attributable to redeemable non-controlling interests<sup>(2)</sup> | (1.0) | (0.6) |
| Net excess tax benefits from stock-based compensation plans activity | (0.2) | (0.2) |
| Valuation allowances | (0.2) | 0.3 |
| Other items | 0.7 | 0.3 |
| Effective income tax rate | 22.8% | 23.5% |
| Adjusted effective tax rate | 23.8% | 24.1% |

---

<sup>(1)</sup> *State income tax benefits are reflected in the total benefits for net income attributable to redeemable non-controlling interests and stock-based compensation plans activity.*

<sup>(2)</sup> *Net income attributable to redeemable non-controlling interests represents the portion of earnings held in the firm's consolidated investment products, which are not taxable to the firm despite being included in pre-tax income.*

The adjusted effective tax rate primarily adjusts for the impact of the consolidated investment products, including the net income attributable to the redeemable non-controlling interests. The decrease in the year-to-date 2025 U.S. GAAP and adjusted effective tax rates compared to 2024 was primarily due to the reversal of a U.S. foreign tax credit carryover valuation allowance and lower state taxes. The impact of redeemable non-controlling interest also contributed to the lower U.S. GAAP effective tax rate compared to the 2024 period.

We currently estimate that our effective tax rate for the full year 2025, on a U.S. GAAP basis, will be in the range of 23.0% to 26.0%. On an adjusted basis, the range is 23.5% to 25.5%.

Our effective tax rate will continue to experience volatility in future periods due to tax benefits recognized from stock-based compensation being influenced by market fluctuations in our stock price, and changes in deferred tax asset valuation allowances, primarily in foreign jurisdictions, being impacted by the sufficiency of taxable income in future periods. Our U.S. GAAP rate will also be impacted by changes in the proportion of net income that is attributable to our redeemable non-controlling interests and non-controlling interests reflected in permanent equity.

------

***<u>NON-GAAP INFORMATION AND RECONCILIATION.</u>***

We believe the non-GAAP financial measures below provide relevant and meaningful information to investors about our core operating results. These measures have been established in order to increase transparency for the purpose of evaluating our core business, for comparing current results with prior period results, and to enable more appropriate comparison with industry peers. However, non-GAAP financial measures should not be considered a substitute for financial measures calculated in accordance with U.S. GAAP and may be calculated differently by other companies.

The following schedules reconcile certain U.S. GAAP financial measures to Non-GAAP financial measures for the three months ended September 30, 2025 and 2024.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** |
| | **Operating expenses** | **Net operating income** | **Non-operating income (loss)** | **Provision (benefit) for income taxes**<sup>(6)</sup> | **Net income attributable to T. Rowe Price Group, Inc.** | **Diluted earnings per share**<sup>(7)</sup> |
| **U.S. GAAP Basis (FS line item)** | $1250.3 | $643.2 | $238.4 | $195.1 | $646.1 | $2.87 |
| Non-GAAP adjustments: |  |  |  |  |  |  |
| Acquisition-related: |  |  |  |  |  |  |
| &nbsp;&nbsp;Investment and NCI amortization and impairments<sup>(1)</sup> (Capital allocation-based income and Compensation and related costs) | 5.8 | 8.4 |  | 1.2 | 7.2 | 0.03 |
| &nbsp;&nbsp;Acquisition-related retention arrangements<sup>(1)</sup> (Compensation and related costs) | (14.2) | 14.2 |  | 2.1 | 12.1 | 0.05 |
| &nbsp;&nbsp;Intangible assets amortization and impairments<sup>(1)</sup>  | (26.8) | 26.8 |  | 3.9 | 22.9 | 0.10 |
| Total acquisition-related | (35.2) | 49.4 |  | 7.2 | 42.2 | 0.18 |
| Deferred compensation liabilities<sup>(2)</sup> (Compensation and related costs) | (50.8) | 50.8 | (53.0) | (0.3) | (1.9) | (0.01) |
| Restructuring charge<sup>(3)</sup> | (28.5) | 28.5 |  | 4.2 | 24.3 | 0.11 |
| Consolidated investment products<sup>(4)</sup> | (1.4) | 2.2 | (72.6) | (4.4) | (25.6) | (0.11) |
| Other non-operating income<sup>(5)</sup> |  |  | (62.6) | (9.2) | (53.4) | (0.23) |
| **Adjusted Basis** | $1134.4 | $774.1 | $50.2 | $192.6 | $631.7 | $2.81 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** | **Three months ended 9/30/2024** |
| | **Operating expenses** | **Net operating income** | **Non-operating income (loss)** | **Provision (benefit) for income taxes**<sup>(6)</sup> | **Net income attributable to T. Rowe Price Group, Inc.** | **Diluted earnings per share**<sup>(7)</sup> |
| **U.S. GAAP Basis (FS line item)** | $1172.0 | $613.6 | $212.5 | $185.7 | $603.0 | $2.64 |
| Non-GAAP adjustments: |  |  |  |  |  |  |
| Acquisition-related: |  |  |  |  |  |  |
| &nbsp;&nbsp;Investment and NCI amortization and impairments<sup>(1)</sup> (Capital allocation-based income and Compensation and related costs) | 13.6 | 16.9 |  | 2.3 | 14.6 | 0.06 |
| &nbsp;&nbsp;Acquisition-related retention arrangements<sup>(1)</sup> (Compensation and related costs) | (4.0) | 4.0 |  | 0.5 | 3.5 | 0.02 |
| &nbsp;&nbsp;Contingent consideration<sup>(1)</sup>  | 13.4 | (13.4) |  | (1.8) | (11.6) | (0.05) |
| &nbsp;&nbsp;Intangible assets amortization and impairments<sup>(1)</sup>  | (51.5) | 51.5 |  | 7.0 | 44.5 | 0.19 |
| Total acquisition-related | (28.5) | 59.0 |  | 8.0 | 51.0 | 0.22 |
| Deferred compensation liabilities<sup>(2)</sup> (Compensation and related costs) | (43.4) | 43.4 | (41.1) | 0.3 | 2.0 | 0.01 |
| Consolidated investment products<sup>(4)</sup> | (1.1) | 2.4 | (85.9) | (6.3) | (39.8) | (0.17) |
| Other non-operating income<sup>(5)</sup> |  |  | (34.3) | (4.6) | (29.7) | (0.13) |
| **Adjusted Basis** | $1099.0 | $718.4 | $51.2 | $183.1 | $586.5 | $2.57 |

---

------

The following schedules reconcile certain U.S. GAAP financial measures to non-GAAP financial measures for the nine months ended September 30, 2025 and 2024.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** | **Nine months ended 9/30/2025** |
| | **Operating expenses** | **Net operating income** | **Non-operating income (loss)** | **Provision (benefit) for income taxes**<sup>(6)</sup> | **Net income attributable to T. Rowe Price Group, Inc.** | **Diluted earnings per share**<sup>(7)</sup> |
| **U.S. GAAP Basis (FS line item)** | $3662.9 | $1717.8 | $544.6 | $514.7 | $1641.8 | $7.25 |
| Non-GAAP adjustments: |  |  |  |  |  |  |
| Acquisition-related: |  |  |  |  |  |  |
| &nbsp;&nbsp;Investment and NCI amortization and impairments<sup>(1)</sup> (Capital allocation-based income and Compensation and related costs) | 24.9 | 36.6 |  | 7.7 | 28.9 | 0.13 |
| &nbsp;&nbsp;Acquisition-related retention arrangements<sup>(1)</sup> (Compensation and related costs) | (42.5) | 42.5 |  | 8.3 | 34.2 | 0.15 |
| &nbsp;&nbsp;Intangible assets amortization and impairments<sup>(1)</sup>  | (86.7) | 86.7 |  | 17.1 | 69.6 | 0.31 |
| Total acquisition-related | (104.3) | 165.8 |  | 33.1 | 132.7 | 0.59 |
| Deferred compensation liabilities<sup>(2)</sup> (Compensation and related costs) | (109.9) | 109.9 | (112.8) | (0.6) | (2.3) | (0.01) |
| Restructuring charge<sup>(3)</sup> | (28.5) | 28.5 |  | 4.2 | 24.3 | 0.11 |
| Consolidated investment products<sup>(4)</sup> | (3.5) | 7.1 | (183.1) | (16.0) | (54.1) | (0.24) |
| Other non-operating income<sup>(5)</sup> |  |  | (115.9) | (21.3) | (94.6) | (0.42) |
| **Adjusted Basis** | $3416.7 | $2029.1 | $132.8 | $514.1 | $1647.8 | $7.28 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** | **Nine months ended 9/30/2024** |
| | **Operating expenses** | **Net operating income** | **Non-operating income (loss)** | **Provision (benefit) for income taxes**<sup>(6)</sup> | **Net income attributable to T. Rowe Price Group, Inc.** | **Diluted earnings per share**<sup>(7)</sup> |
| **U.S. GAAP Basis (FS line item)** | $3504.2 | $1764.9 | $481.7 | $527.5 | $1660.2 | $7.23 |
| Non-GAAP adjustments: |  |  |  |  |  |  |
| Acquisition-related: |  |  |  |  |  |  |
| &nbsp;&nbsp;Investment and NCI amortization and impairments<sup>(1)</sup> (Capital allocation-based income and Compensation and related costs) | 29.8 | 40.0 |  | 7.8 | 32.2 | 0.14 |
| &nbsp;&nbsp;Acquisition-related retention arrangements<sup>(1)</sup> (Compensation and related costs) | (30.6) | 30.6 |  | 7.2 | 23.4 | 0.10 |
| &nbsp;&nbsp;Contingent consideration<sup>(1)</sup>  | 13.4 | (13.4) |  | (1.8) | (11.6) | (0.05) |
| &nbsp;&nbsp;Intangible assets amortization and impairments<sup>(1)</sup>  | (125.3) | 125.3 |  | 24.9 | 100.4 | 0.44 |
| Total acquisition-related | (112.7) | 182.5 |  | 38.1 | 144.4 | 0.63 |
| Deferred compensation liabilities<sup>(2)</sup> (Compensation and related costs) | (111.0) | 111.0 | (105.6) | 1.2 | 4.2 | 0.02 |
| Consolidated investment products<sup>(4)</sup> | (4.3) | 7.3 | (166.7) | (21.2) | (79.3) | (0.35) |
| Other non-operating income<sup>(5)</sup> |  |  | (95.0) | (20.2) | (74.8) | (0.32) |
| **Adjusted Basis** | $3276.2 | $2065.7 | $114.4 | $525.4 | $1654.7 | $7.21 |

---

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;These non-GAAP adjustments remove the impact of acquisition-related amortization of intangible assets, the recurring fair value remeasurements of the contingent consideration liability, if any, amortization of acquired investment and non-controlling interest basis differences and amortization of compensation-related arrangements. We believe adjusting for these charges helps the reader's ability to understand our core operating results and increases comparability period to period.

<sup>(2)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP adjustment eliminates the compensation expense impact from market valuation changes in deferred compensation liabilities, including the supplemental savings plan and, starting in Q4 2024, restricted fund units, and the related net gains (losses) on investments used as economic hedges against the related liabilities. The liabilities are adjusted based on the performance of hypothetical investments selected by participants. We use investment products to economically hedge the market risk associated with the supplemental savings plan liability and the expected settlement

------

value of unvested restricted fund units. We believe it is useful to offset the non-operating investment income (loss) of the hedges against the related compensation expense and remove the net impact to help the reader's ability to understand the firm's core operating results and to increase comparability period to period.

<sup>(3)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP adjustment removes compensation expenses, primarily severance, incurred as part of our broad and ongoing plan to reduce expense growth and realign resources to invest in existing and future capabilities. We believe this adjustment helps the reader's ability to understand our core operating results and increases comparability period to period.

<sup>(4)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP adjustment removes the impact of the consolidated investment products by adding back their operating expenses and subtracting their investment income. The operating expense adjustment represents their operating expenses net of related investment advisory and administrative fees. The adjustment to net income attributable to T. Rowe Price Group, Inc. represents the consolidated investment products' net income, net of redeemable non-controlling interests. We believe this adjustment helps the reader's ability to understand our core operating results and increases comparability period to period.

<sup>(5)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP adjustment removes non-operating income (loss) earned on those investments that are not economic hedges for the deferred compensation liabilities and are not part of the cash and discretionary investment portfolio. We retain gains from cash and discretionary investments in our non-GAAP measures, as they are considered part of our core operations. We believe adjusting for the remaining non-operating income (loss) helps the reader's ability to understand the firm's core operating results and increases comparability period to period. Additionally, we do not emphasize this portion of non-operating income (loss) when assessing the firm's performance.

<sup>(6)</sup> &nbsp;&nbsp;&nbsp;&nbsp;The income tax impacts were calculated in order to achieve an overall year-to-date non-GAAP effective tax rate of 23.8% in 2025 and 24.1% in 2024. As such, the non-GAAP effective tax rate for the third quarter was 23.4% in 2025 and 23.8% in 2024.

<sup>(7)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP measure was calculated by applying the two-class method to adjusted net income attributable to T. Rowe Price Group, Inc. divided by the weighted-average common shares outstanding assuming dilution. The calculation of adjusted net income allocated to common stockholders is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Nine months ended** | **Nine months ended** |
| (in millions) | **9/30/2025** | **9/30/2024** | **9/30/2025** | **9/30/2024** |
| Adjusted net income attributable to T. Rowe Price Group, Inc. | $631.7 | $586.5 | $1647.8 | $1654.7 |
| Less: adjusted net income allocated to outstanding restricted stock and stock unit holders | 14.3 | 15.0 | 39.7 | 44.1 |
| Adjusted net income allocated to common stockholders | $617.4 | $571.5 | $1608.1 | $1610.6 |

---

***<u>CAPITAL RESOURCES AND LIQUIDITY.</u>***

**<u>Sources of Liquidity</u>**

We have ample liquidity, including cash and investments in T. Rowe Price products, as follows:

---

| | | |
|:---|:---|:---|
| (in millions) | **9/30/2025** | **12/31/2024** |
| Cash and cash equivalents | $3634.8 | $2649.8 |
| Discretionary investments | 643.6 | 457.1 |
| Total cash and discretionary investments | 4278.4 | 3106.9 |
| Redeemable seed capital investments | 1054.5 | 1262.3 |
| Investments used to hedge the deferred compensation liabilities | 1158.6 | 1110.9 |
| Total cash and investments in T. Rowe Price products | $6491.5 | $5480.1 |

---

Our discretionary investment portfolio is primarily comprised of short duration bond funds, which typically yield higher than money market rates. Our subsidiaries outside the United States held cash and discretionary investments of $812.2 million at September 30, 2025 and $653.9 million at December 31, 2024. Given the availability of our financial resources and cash expected to be generated through future operations, we do not maintain an available external source of additional liquidity.

------

Our seed capital investments are redeemable, although we generally expect to be invested for several years for the products to build an investment performance history and until unrelated third-party investors substantially reduce our relative ownership percentage.

The cash and investment presentation on the unaudited consolidated balance sheet is based on the accounting treatment for the cash equivalent or investment item. The following table details how T. Rowe Price Group, Inc.'s interests in cash and investments relate to where they are presented on the unaudited consolidated balance sheet as of September 30, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| (in millions) | **Cash and cash equivalents** | **Investments** | **Net assets of consolidated investment products**<sup>(1)</sup> | **Total** |
| Cash and discretionary investments | $3634.8 | $592.6 | $51.0 | $4278.4 |
| Seed capital investments |  | 383.2 | 671.3 | 1054.5 |
| Investments used to hedge the deferred compensation liabilities |  | 1110.8 | 47.8 | 1158.6 |
| Total cash and investments in T. Rowe Price products attributable to T. Rowe Price Group, Inc. | 3634.8 | 2086.6 | 770.1 | 6491.5 |
| Investments in affiliated private investment funds<sup>(2)</sup> |  | 705.8 |  | 705.8 |
| Investments in CLOs |  | 38.2 |  | 38.2 |
| Investment in UTI and other investments |  | 586.8 |  | 586.8 |
| Total cash and investments attributable to T. Rowe Price Group, Inc. | 3634.8 | 3417.4 | 770.1 | 7822.3 |
| Redeemable non-controlling interests |  |  | 984.9 | 984.9 |
| As reported on unaudited consolidated balance sheet at September 30, 2025 | $3634.8 | $3417.4 | $1755.0 | $8807.2 |

---

<sup>(1)</sup> *The consolidated investment products are generally those products we provided seed capital at the time of their formation and we have a controlling interest. These products generally represent U.S. mutual funds, ETFs, and funds regulated outside the U.S. The $770.1 million represents the total value at September 30, 2025 of our interest in the consolidated investment products. The total net assets of the T. Rowe Price investment products at September 30, 2025 of $1,755.0 million includes assets of $1,777.7 million, less liabilities of $22.7 million as reflected in our unaudited consolidated balance sheets.* 

<sup>(2)</sup> *Includes $170.0 million of non-controlling interests in consolidated entities held by related parties, and we cannot sell in order to obtain cash for general operations.*

Our unaudited consolidated balance sheet includes the cash, investments, and other assets and liabilities of our consolidated investment products, which includes any redeemable non-controlling interests held by third-party investors. While we can redeem our net interest in these investment products at any time, we cannot directly access or sell their assets for general operations, and their assets are not available to our general creditors. Our interest typically serves as initial seed capital and is reclassified as discretionary when management decides the seed capital is no longer needed. We evaluate these discretionary investment products and aim to liquidate our interest without affecting the product or unrelated third-party investors.

**<u>Uses of Liquidity</u>**

------

Since the end of 2022, we have returned $4.2 billion to stockholders through stock repurchases and regular quarterly dividends, as follows:

---

| | | | |
|:---|:---|:---|:---|
| (in millions) | **Recurring dividend** | **Stock repurchases** | **Total cash returned to stockholders** |
| 2023 | $1121.9 | $254.3 | $1376.2 |
| 2024 | 1135.2 | 334.5 | 1469.7 |
| Nine months ended 9/30/2025 | 858.7 | 483.8 | 1342.5 |
| Total | $3115.8 | $1072.6 | $4188.4 |

---

We anticipate property, equipment, software and other capital expenditures, including internal labor capitalization, for the full-year 2025 to be about $275 million of which over 80% is planned for technology initiatives. We expect to fund our anticipated capital expenditures with operating cash flows and other available resources.

------

**<u>Cash Flows</u>**

The following table summarizes the cash flows for the nine months ended September 30, 2025 and 2024, that are attributable to T. Rowe Price Group, Inc., our consolidated investment products, and the related eliminations required in preparing the statement.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine months ended** | **Nine months ended** | **Nine months ended** | **Nine months ended** | **Nine months ended** | **Nine months ended** | **Nine months ended** | **Nine months ended** |
| | **9/30/2025** | **9/30/2025** | **9/30/2025** | **9/30/2025** | **9/30/2024** | **9/30/2024** | **9/30/2024** | **9/30/2024** |
| (in millions) | **Cash flow attributable to T. Rowe Price Group, Inc.** | **Cash flow attributable to consolidated investment products** | **Elims** | **As reported**  | **Cash flow attributable to T. Rowe Price Group, Inc.** | **Cash flow attributable to consolidated investment products** | **Elims** | **As reported**  |
| Cash flows from operating activities |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net income (loss) | $1641.8 | $176.0 | $(70.1) | $1747.7 | $1660.2 | $159.4 | $(100.5) | $1719.1 |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation, amortization and impairments of property, equipment and software | 203.7 |  |  | 203.7 | 188.4 |  |  | 188.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization and impairment of acquisition-related assets and retention agreements | 165.8 |  |  | 165.8 | 196.5 |  |  | 196.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fair value remeasurement of contingent liability |  |  |  |  | (13.4) |  |  | (13.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 134.2 |  |  | 134.2 | 162.2 |  |  | 162.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (gains) losses recognized on investments | (417.6) |  | 70.1 | (347.5) | (432.6) |  | 100.5 | (332.1) |
| &nbsp;&nbsp;&nbsp;Total non-cash adjustments | 86.1 |  | 70.1 | 156.2 | 101.1 |  | 100.5 | 201.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net redemptions in T. Rowe Price investment products used to economically hedge deferred compensation liabilities | 63.3 |  | 46.7 | 110.0 | 29.8 |  |  | 29.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in trading securities held by consolidated investment products |  | (821.4) |  | (821.4) |  | (517.9) |  | (517.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other changes | 588.8 | (1.1) | (8.1) | 579.6 | 548.3 | 5.7 | (19.1) | 534.9 |
| Net cash provided by (used in) operating activities | 2380.0 | (646.5) | 38.6 | 1772.1 | 2339.4 | (352.8) | (19.1) | 1967.5 |
| Net cash provided by (used in) investing activities | (79.3) | (35.8) | 96.2 | (18.9) | (143.1) | (15.7) | 3.8 | (155.0) |
| Net cash provided by (used in) financing activities | (1315.7) | 664.9 | (134.8) | (785.6) | (1089.4) | 345.9 | 15.3 | (728.2) |
| Effect of exchange rate changes on cash and cash equivalents of consolidated investment products |  | 3.4 |  | 3.4 |  | 0.5 |  | 0.5 |
| Net change in cash and cash equivalents during period | 985.0 | (14.0) |  | 971.0 | 1106.9 | (22.1) |  | 1084.8 |
| Cash and cash equivalents at beginning of year | 2649.8 | 63.1 |  | 2712.9 | 2066.6 | 77.2 |  | 2143.8 |
| Cash and cash equivalents at end of period | $3634.8 | $49.1 | $— | $3683.9 | $3173.5 | $55.1 | $— | $3228.6 |

---

------

*<u>Operating Activities</u>*

Operating activities attributable to T. Rowe Price Group, Inc. provided cash flows of $2,380.0 million during the first nine months of 2025, an increase of $40.6 million from $2,339.4 million provided during the 2024 period. The increase was primarily driven by a $40.5 million increase in cash flows related to timing differences in the cash settlement of our assets and liabilities. Additionally, in 2025, net redemptions from certain investment products that economically hedge our deferred compensation liabilities were $33.5 million higher as compared to the 2024 period. These increases were offset in part by a $18.4 million decrease in net income and a $15.0 million decrease in the add-back for non-cash items as detailed in the table above. The remaining change in reported cash flows from operating activities was attributable to the net change in trading securities held in our consolidated investment products' underlying portfolios.

Our interim operating cash flows does not include the cash impact of variable compensation that is accrued throughout the year before being substantially paid out in December.

***<u>I</u>****<u>nvesting Activities</u>*

Net cash used in investing activities attributable to T. Rowe Price Group, Inc. totaled $79.3 million in 2025 compared with $143.1 million in 2024. In 2025, we decreased our property and equipment expenditures by $102.9 million and had higher net proceeds from the sale of sponsored investment products. We had net proceeds from the sale of investments of $241.9 million in the 2025 period compared to $209.9 million during the 2024 period. Partially offsetting these changes was an increase in other investing activity of $71.1 million compared to the 2024 period. We eliminate our capital in our consolidated investment products in preparing our consolidated statements of cash flows. The remaining change in reported cash flows from investing activities of $20.1 million is related to the net cash removed from our unaudited consolidated balance sheet from consolidating and deconsolidating investment products.

*<u>Financing Activities</u>*

Net cash used in financing activities attributable to T. Rowe Price Group, Inc. totaled $1,315.7 million in 2025 compared with $1,089.4 million in 2024. During 2025, we used $481.8 million to repurchase 4.8 million shares compared to $269.1 million to repurchase 2.3 million shares in 2024. The $7.5 million increase in dividends paid in 2025 was a result of the 2.4% increase in our quarterly dividend per share over prior year. The remaining change in reported cash flows from financing activities was primarily attributable to a $168.9 million increase in net subscriptions from redeemable non-controlling interest holders of our consolidated investment products during 2025.

***<u>CRITICAL ACCOUNTING POLICIES.</u>***

The preparation of financial statements often requires the selection of specific accounting methods and policies from among several acceptable alternatives. Further, significant estimates and judgments may be required in selecting and applying those methods and policies in the recognition of the assets and liabilities in our unaudited consolidated balance sheets, the revenues and expenses in our unaudited consolidated statements of income, and the information that is contained in our significant accounting policies and notes to the unaudited consolidated financial statements. Making these estimates and judgments requires the analysis of information concerning events that may not yet be complete and of facts and circumstances that may change over time. Accordingly, actual amounts or future results can differ materially from those estimates that we include currently in our unaudited consolidated financial statements, significant accounting policies, and notes.

There have been no material changes in the critical accounting policies previously identified in our 2024 Annual Report on Form 10-K.

***<u>NEWLY-ISSUED BUT NOT YET ADOPTED ACCOUNTING GUIDANCE.</u>***

See Note 1 - The Company and Basis of Preparation note within Item 1. Financial Statements for a discussion of newly issued but not yet adopted accounting guidance.

------

***<u>FORWARD-LOOKING INFORMATION.</u>***

From time to time, information or statements provided by or on behalf of T. Rowe Price Group, Inc., including those within this report, may contain certain forward-looking information, including information or anticipated information relating to: our revenues, net income, and earnings per share of common stock; changes in the amount and composition of our assets under management; our expense levels, tax rate, dividends, stock repurchases, investments, new products and services, capital expenditures, changes in our effective fee rate, and potential transactions; legal or regulatory developments; geopolitical instability; interest rates and currency fluctuations; our expectations regarding financial markets and other industry or market conditions. Readers are cautioned that any forward-looking information provided by or on behalf of T. Rowe Price Group, Inc. is not a guarantee of future performance. Actual results may differ materially from those in forward-looking information because of various factors including, but not limited to, those discussed below and in Item 1A, Risk Factors, included in our Form 10-K Annual Report for 2024. Further, forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which it is made or to reflect the occurrence of unanticipated events.

Our future revenues and results of operations will fluctuate primarily due to changes in the total value and composition of assets under our management. Such changes result from many factors, including, among other things: client-related cash inflows and outflows in our products, performance fees, capital allocation-based income, fluctuations in global financial markets that result in appreciation or depreciation of the assets under our management, our introduction of new investment products, and changes in retirement savings trends relative to participant-directed investments and defined contribution plans.

Our ability to attract and retain investors' assets under our management is dependent on investor sentiment and confidence, including: changes thereto that may result from U.S. trade policies, market volatility and economic outlook; the relative investment performance of the T. Rowe Price mutual funds and other managed investment products as compared with competing offerings and market indexes; the ability to maintain our investment management and administrative fees at appropriate levels; the impact of changes in interest rates and inflation; competitive conditions in the mutual fund, asset management, and broader financial services sectors; our level of success in implementing our strategy to expand our business; and our ability to attract and retain key personnel. Our revenues are substantially dependent on fees earned under contracts with the T. Rowe Price funds and could be adversely affected if the independent directors of one or more of the T. Rowe Price funds terminated or significantly altered the terms of the investment management or related administrative services agreements. Non-operating investment income will also fluctuate primarily due to the size of our investments, changes in their market valuations, and any other-than-temporary impairments that may arise or, in the case of our equity method investments, our proportionate share of the investees' net income.

Our future results are also dependent upon the level of our expenses, which are subject to fluctuation for the following or other reasons: changes in the level of our advertising and promotion expenses in response to market conditions, including our efforts to expand our investment advisory business to investors outside the U.S. and to further penetrate our distribution channels within the U.S.; the pace and level of spending to support key strategic priorities; variations in the level of total compensation expense due to, among other things, bonuses, restricted stock units and other equity grants, other incentive awards, our supplemental savings plan, changes in our employee count and mix, and competitive factors; any goodwill, intangible asset or other asset impairment that may arise; fluctuation in foreign currency exchange rates applicable to the costs of our international operations; expenses and capital costs, such as technology assets, depreciation, amortization, and research and development, incurred to maintain and enhance our administrative and operating services infrastructure; the timing of the assumption of all third party research payments, unanticipated costs that may be incurred to protect investor accounts and the goodwill of our clients; and disruptions of services, including those provided by third parties, such as fund and product recordkeeping, facilities, communications, power, and the mutual fund transfer agent and accounting systems, as a result of extreme events, cyberattacks or otherwise.

Our business is also subject to substantial governmental regulation, and changes in legal, regulatory, accounting, tax, and compliance requirements may have a substantial effect on our operations and results, including, but not limited to, effects on costs that we incur and effects on investor interest in investment products and investing in general or in particular classes of mutual funds or other investments.

------

**Item 3. Quantitative and Qualitative Disclosures About Market Risk.** 

There has been no material change in our market risks from those provided in Item 7A of the Form 10-K Annual Report for 2024.

**Item 4. Controls and Procedures.** 

Our management, including our principal executive and principal financial officers, has evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2025. Based on that evaluation, our principal executive and principal financial officers have concluded that our disclosure controls and procedures as of September 30, 2025, are effective at the reasonable assurance level to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, including this Form 10-Q quarterly report, is recorded, processed, summarized, and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms, and to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Our management, including our principal executive and principal financial officers, has evaluated any change in our internal control over financial reporting that occurred during the third quarter of 2025, and has concluded that there was no change during the third quarter of 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

**PART II – OTHER INFORMATION**

**Item 1. Legal Proceedings.**

For information about our legal proceedings, please see our Commitments and Contingencies footnote to our unaudited consolidated financial statements in Part 1 of this Form 10-Q.

**Item 1A. Risk Factors.**

There have been no material changes in the information provided in Item 1A of our Form 10-K Annual Report for 2024.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.** 

(c) Repurchase activity during the third quarter of 2025 is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Month** | **Total Number of**<br>**Shares Purchased** | **Average Price**<br>**Paid per Share** | **Total Number of**<br>**Shares Purchased as**<br>**Part of Publicly**<br>**Announced Program** | **Maximum Number of Shares that May Yet Be Purchased Under the Program** |
| July 1 - July 31 | 222504 | $103.29 | 220000 | 14805865 |
| August 1 - August 31 | 525056 | $106.74 | 514565 | 14291300 |
| September 1 - September 30 | 747590 | $104.99 | 722923 | 13568377 |
| Total | 1495150 | $105.35 | 1457488 |  |

---

Shares repurchased by us in a quarter may include repurchases conducted pursuant to publicly announced board authorization, outstanding shares surrendered to us to pay the exercise price in connection with swap exercises of employee stock options, and shares withheld to cover the minimum tax withholding obligation associated with the vesting of restricted stock awards. Of the total number of shares purchased during the third quarter of 2025, 37,662 were related to shares surrendered in connection with employee stock option exercises and no shares were withheld to cover tax withholdings associated with the vesting of restricted stock awards.

------

The following table details the changes in and status of the Board of Directors' outstanding publicly announced board authorizations.

---

| | | | |
|:---|:---|:---|:---|
| **Authorization Dates** | **Maximum Number of Shares that May Yet Be Purchased at 7/1/2025** | **Total Number of<br>Shares Purchased** | **Maximum Number of Shares that May Yet Be Purchased at 9/30/2025** |
| March 2020 | 25865 | (25865) |  |
| December 2024 | 15000000 | (1431623) | 13568377 |
|  | 15025865 | (1457488) | 13568377 |

---

**Item 3. Defaults Upon Senior Securities.**

Not applicable.

**Item 4. Mine Safety Disclosures.** 

Not applicable.

**Item 5. Other Information.**

(a) On October 28, 2025, the Board of Directors approved a plan to exit two owned office buildings in Owings Mills, Maryland. This decision is expected to result in a non-cash charge of up to $100 million in the fourth quarter of 2025, primarily reflecting the carrying value of the buildings. This decision was made in connection with the firm's broad and ongoing plan to reduce expense growth and realign resources to invest in existing and future capabilities.

**Item 6. Exhibits.**

The following exhibits required by Item 601 of Regulation S-K are filed herewith, except for Exhibit 32 that is furnished herewith.

---

| | |
|:---|:---|
| 3(i) | [Charter of T. Rowe Price Group, Inc., as reflected by Articles of Restatement dated June 20, 2018. (Incorporated by reference from Form 10-Q Quarterly Report filed on July 25, 2018.)](https://www.sec.gov/Archives/edgar/data/1113169/000111316918000018/articlesofrestatementfin.htm) |
| 3(ii) | [Amended and Restated By-Laws of T. Rowe Price Group, Inc. as of February 9, 2021. (Incorporated by reference from Form 10-K Annual Report filed on February 11, 2021.)](https://www.sec.gov/Archives/edgar/data/1113169/000111316921000006/exhibit3-1trpgamendedandre.htm) |
| 15 | [Report from KPMG LLP, independent registered public accounting firm, re unaudited interim financial information.](trow-ex15_q32025.htm) |
| 31(i).1 | [Rule 13a-14(a) Certification of Principal Executive Officer.](trow-ex31i1_q32025.htm) |
| 31(i).2 | [Rule 13a-14(a) Certification of Principal Financial Officer.](trow-ex31i2_q32025.htm) |
| 32 | [Section 1350 Certifications.](trow-ex32_q32025.htm) |
| 101 | The following series of unaudited XBRL-formatted documents are collectively included herewith as Exhibit 101. The financial information is extracted from T. Rowe Price Group, Inc.'s unaudited consolidated interim financial statements and notes that are included in this Form 10-Q Report. |
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | XBRL Taxonomy Extension Schema Document |
| 101.CAL | XBRL Taxonomy Calculation Linkbase Document |
| 101.LAB | XBRL Taxonomy Label Linkbase Document |
| 101.PRE | XBRL Taxonomy Presentation Linkbase Document |
| 101.DEF | XBRL Taxonomy Definition Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on October 31, 2025.

T. Rowe Price Group, Inc.

By:&nbsp;&nbsp;&nbsp;&nbsp;/s/ Jennifer B. Dardis

Vice President, Chief Financial Officer and Treasurer

## Ex-15

EXHIBIT 15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Letter from KPMG LLP, independent registered public accounting firm, re unaudited interim financial information

October 31, 2025

T. Rowe Price Group, Inc.

Baltimore, Maryland

Re: Registration Statements No. 033-7012, No. 333-59714, No. 333-120882, No. 333-120883, No. 333-142092, No. 333-167317, No. 333-180904, No. 333-199560, No. 333-212705 , No. 333-217483, No. 333-238319, and No. 333-273601.

With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report dated October 31, 2025 related to our review of interim financial information.

Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.

/s/ KPMG LLP

Baltimore, Maryland

## Ex-31

EXHIBIT 31(i).1 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rule 13a-14(a) Certification of Principal Executive Officer

I, Robert W. Sharps, certify that:

1. I have reviewed this Form 10-Q Quarterly Report for the quarterly period ended September 30, 2025 of T. Rowe Price Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

October 31, 2025

/s/ Robert W. Sharps

Chief Executive Officer and President

## Ex-31

EXHIBIT 31(i).2 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rule 13a-14(a) Certification of Principal Financial Officer

I, Jennifer B. Dardis, certify that:

1. I have reviewed this Form 10-Q Quarterly Report for the quarterly period ended September 30, 2025 of T. Rowe Price Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

October 31, 2025

/s/ Jennifer B. Dardis

Vice President, Chief Financial Officer and Treasurer

## Ex-32

EXHIBIT 32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Section 1350 Certifications&nbsp;&nbsp;&nbsp;&nbsp;

We certify, to the best of our knowledge, based upon a review of the Form 10-Q Quarterly Report for the quarterly period ended September 30, 2025, of T. Rowe Price Group, Inc., that:

(1) The Form 10-Q Quarterly Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Form 10-Q Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of T. Rowe Price Group, Inc.

October 31, 2025

/s/ Robert W. Sharps

Chief Executive Officer and President

/s/ Jennifer B. Dardis

Vice President, Chief Financial Officer and Treasurer

<br>